P4 - Poster Session 4

Event Time:	Wednesday May 8, 2019 11:30 am to 6:30 pm
Topic(s):	Practice, Policy, and Ethics, General Neurology, Aging, Dementia, Cognitive, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), Headache, Infectious Disease, Movement Disorders, MS and CNS Inflammatory Disease, Neuroepidemiology, Neuromuscular and Clinical Neurophysiology (EMG), Research Methodology, Education, and History
Director(s):
Description:
Completion Message:
CME Credits:	0
Core Competencies:

Program Speakers - Tentative
Start/End Time	Title	Faculty
Currently there are no events in the timeline.

Disclosures
Speaker	Disclosure

Abstract Presenters
Movement Disorders ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	001	Substantia Nigra (SN) Hyperechogenicity is a Reliable Biomarker for Disease Progression From Stage I to Stage II in Early Onset Parkinson’s Disease (EOPD)	Disclosure: Dr. Ravi has nothing to disclose.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	001	A Randomized Trial of Telemedicine for Migraine Management	Disclosure: Dr. Friedman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alder Biopharmaceuticals, Allergan, Amgen, Biohaven, electroCore, Eli Lilly, Promius, Revance, Supernus, Teva, Theranica and Zosano. Dr. Friedman has received personal compensation in an editorial capacity for Neurology Reviews. Dr. Friedman has received research support from Allergan, Autonomic Technologies, Inc (company entered into insolvency April 2019), Eli Lilly, Merck, Zosano.
Check Point Inhibitors and Paraneoplastic Neurological Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	001	Neurologic Adverse Events associated with Immune Checkpoint Inhibitor Therapy	Disclosure: Dr. Duong has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	001	Mid-Atlantic Region State Ratios of Emergency Hyperbaric Chambers (EHC) to Comprehensive Stroke Centers (CSC) for Symptomatic Cerebral Air Embolus (SCAE)	Disclosure: Dr. Taylor has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	001	A case of aggressive motor neuron disease without profound loss of motor neuron cells	Disclosure: Dr. Liu has nothing to disclose.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	001	Lack of Standardization of the Level of Encephalopathy on EEG: a Barrier to the Widespread Use of EEG for Brain Monitoring	Disclosure: Dr. Maciel has nothing to disclose.
Neuroepidemiology: ALS, MS, Parkinson's Disease and Epilepsy
Start Time	Pub.	Title	Presenter
11:30 AM	001	Clinical Characteristics of a Large Cohort of US Patients Enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010–2015	Disclosure: Dr. Raymond MPH has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	001	Muscle pattern changes in patients with cervical dystonia (CD) receiving botulinum toxin (BTX)	Disclosure: Dr. Gutflais has nothing to disclose.
NeuroHIV and other Retroviruses
Start Time	Pub.	Title	Presenter
11:30 AM	001	Cognitive Performance and Total and Regional Brain Volumes in Zambian Youth with HIV	Disclosure: Dr. Dean has nothing to disclose.
Aging and Dementia: Clinical Trials
Start Time	Pub.	Title	Presenter
11:30 AM	002	Baseline Characteristics from a Phase III Trial of Crenezumab in Early (Prodromal-to-Mild) Alzheimer’s Disease (CREAD)	Disclosure: Dr. Sink has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities as a full time employee of Genentech, Inc.
Movement Disorders ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	002	The Pseudodystonia: Important Pitfalls in the Diagnosis of Dystonia	Disclosure: Dr. Pan has nothing to disclose.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	002	Predictors of Non-Adherence with Acute Migraine Medications	Disclosure: Dr. Lofchie has nothing to disclose.
Check Point Inhibitors and Paraneoplastic Neurological Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	002	Pembrolizumab-Associated Paraneoplastic Disorders: A Case Series	Disclosure: Dr. Gill has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	002	Unusual Cause of Acute Ischemic Stroke: A Case of Cerebral Air Embolism Post Transthoracic Lung Biopsy	Disclosure: Dr. Fahimi has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	002	Correlation between Slow Vital Capacity Measured in the Home and in the Clinic for Patients with Amyotrophic Lateral Sclerosis	Disclosure: Dr. Meng has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Cytokinetics employee.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	002	The Sounds of Seizures: Audio-Triggered Detection by Convolutional Neural Network (CNN)	Disclosure: Dr. Basha has nothing to disclose.
Neuroepidemiology: ALS, MS, Parkinson's Disease and Epilepsy
Start Time	Pub.	Title	Presenter
11:30 AM	002	A comparison of the clinical and genetic features of Amyotrophic Lateral Sclerosis across Latin American and European populations	Disclosure: Dr. Hardiman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Wave Life Sciences, Cytokinetics, Treeway. Dr. Hardiman has received personal compensation in an editorial capacity for Taylor and Francis .
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	002	Long-term outcomes of late deep brain stimulation in DYT1 dystonia	Disclosure: Dr. Ooi has nothing to disclose.
NeuroHIV and other Retroviruses
Start Time	Pub.	Title	Presenter
11:30 AM	002	Increased Caloric Intake is Associated with Lower Cognitive Scores in HIV-Positive Women	Disclosure: Dr. Warrior has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with John Redmond Esq.
Movement Disorders ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	003	Disruption of spermatogenesis and infertility in Ataxia with Oculomotor Apraxia Type 2 (AOA2)	Disclosure: Dr. Fogel has nothing to disclose.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	003	Rates of Associated Health Conditions in Those with Migraine vs. Non-migraine Controls: Results from the 2017 Migraine in America Symptoms and Treatment (MAST) Study	Disclosure: Dr. Buse has received personal compensation for consulting serving on a scientific advisory board speaking or other activities with Dawn Buse PhD has received honoraria from Allergan Amgen Biohaven Lilly Teva and Promius. Dr. Buse has received personal compensation in an editorial capacity for editorial board of Current Pain and Headache Reports. Dr. Buse has received research support from Amgen.
Check Point Inhibitors and Paraneoplastic Neurological Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	003	Immune checkpoint inhibitor induced anti-GAD limbic encephalitis	Disclosure: Dr. Chung has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	003	A Rare Case of Air Embolus During Administration of tPA for Acute Ischemic Stroke	Disclosure: Dr. Southard has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	003	Survival prediction models in motor neuron disease	Disclosure: Dr. Spinelli has nothing to disclose.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	003	Long-term Stability of Interictal Spike Trajectories in Pediatric Invasive EEG Recordings	Disclosure: Dr. Tomlinson has nothing to disclose.
Neuroepidemiology: ALS, MS, Parkinson's Disease and Epilepsy
Start Time	Pub.	Title	Presenter
11:30 AM	003	Incidence of Venous Thromboembolic Events Among Amyotrophic Lateral Sclerosis Patients in a US Health Insurance Claims Database	Disclosure: Dr. Kupelian has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	003	Pilot feasibility study of a semi-automated three-dimensional scoring system for cervical dystonia	Disclosure: Dr. Oyama has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Medtronic, Boston Scientific, Otsuka Pharmaceutical, Sumitomo Dainippon Pharma, FP Pharmaceutical Corporation, and Kyowa Hakko Kirin, and Abbvie.
NeuroHIV and other Retroviruses
Start Time	Pub.	Title	Presenter
11:30 AM	003	Rare Case of Human T-lymphotropic Virus-1 (HTLV-1) with Amyotrophic lateral sclerosis	Disclosure: Dr. Khosa has nothing to disclose.
Aging and Dementia: Clinical Trials
Start Time	Pub.	Title	Presenter
11:30 AM	004	GeneMatch: A Novel Recruitment Registry using APOE Genotyping to Accelerate Referrals to Alzheimer’s Prevention Studies	Disclosure: Dr. Langbaum has received research support from Avid/Eli Lilly, Genentech/Roche, Novartis/Amgen.
Movement Disorders ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	004	A single ascending dose (SAD) study of a D1 receptor positive allosteric modulator (LY3154207) in healthy volunteers	Disclosure: Dr. Svensson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eli Lilly and Company. Dr. Svensson holds stock and/or stock options in Eli Lilly and Company.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	004	Undiagnosed Chronic Migraine Is Associated With Higher Economic Burden Compared With Diagnosed Chronic Migraine: Results From a Claims-Based Retrospective Study	Disclosure: Dr. Marcus has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Allergan.
Check Point Inhibitors and Paraneoplastic Neurological Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	004	Characterization of Encephalopathy Associated with Immune Checkpoint Inhibitor Therapy	Disclosure: Dr. Wei has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	004	A case of accidental ingestion of Hydrogen Peroxide causing massive cerebral gas embolic strokes	Disclosure: Dr. Bhattacharyya has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	004	Meta-analysis of Genetic Expression Profiles in Amyotrophic Lateral Sclerosis	Disclosure: Dr. Frank has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with uniQure, Oscine Therapeutics and Sage Therapeutics.. Dr. Frank has received research support from Roche/Genentech and Vaccinex/Huntington Study Group..
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	004	EEG source localization comparing low-density EEG including subtemporal coverage with high density EEG	Disclosure: Dr. Danoun has nothing to disclose.
Neuroepidemiology: ALS, MS, Parkinson's Disease and Epilepsy
Start Time	Pub.	Title	Presenter
11:30 AM	004	Progression of Symptoms in relation to the Site of Onset in Amyotrophic Lateral Sclerosis: new Evidence supporting the Prion-like Hypothesis	Disclosure: Dr. Chio has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, Cytokinetics, Roche. Dr. Chio has received research support from Italfarmaco.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	004	The Dystonia Coalition Natural History Project: Nine Years of Progress	Disclosure: Dr. Norris has nothing to disclose.
NeuroHIV and other Retroviruses
Start Time	Pub.	Title	Presenter
11:30 AM	004	Teriflunomide Reduces Spontaneous Lymphoproliferation of Peripheral Blood Mononuclear Cells From Patients With Human T-Lymphotropic Virus (HTLV)-1–Associated Myelopathy/Tropical Spastic Paraparesis	Disclosure: Dr. Akahata has nothing to disclose.
Aging and Dementia: Clinical Trials
Start Time	Pub.	Title	Presenter
11:30 AM	005	The Alzheimer Prevention Initiative Generation Program: Evaluation of CNP520 in Preclinical Alzheimer's Disease	Disclosure: Dr. Borowsky has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novartis and Teva.
Movement Disorders ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	005	Preliminary validation of a novel, comprehensive digital biomarker smartphone application to assess motor symptoms in recently diagnosed Parkinson patients	Disclosure: Dr. Lipsmeier has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with F. Hoffmann-La Roche Ltd.. Dr. Lipsmeier has received royalty, license fees, or contractual rights payments from F. Hoffmann-La Roche Ltd..
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	005	Poor Acute Treatment Optimization and Frequent Nausea in Episodic Migraine (EM) are Associated with New Onset Chronic Migraine (CM): Results from 2017 Migraine in America Symptoms and Treatment (MAST) Study	Disclosure: Dr. Schwedt has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alder, Allergan, Amgen, Avanir, Cipla, Dr. Reddy’s Laboratories, Eli Lilly, Ipsen Bioscience, Novartis, Salvia, Teva, and XoC Pharmaceuticals. Dr. Schwedt has received personal compensation in an editorial capacity for Associate Editor for Headache and Cephalalgia journals. . Dr. Schwedt has received compensation for serving on the Board of Directors of Aural Analytics and Nocira. Dr. Schwedt has received research support from Amgen.
Check Point Inhibitors and Paraneoplastic Neurological Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	005	Nivolumab-induced myasthenia gravis with myositis in patients with genitourinary cancer	Disclosure: Dr. Sun has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	005	Cerebral Fat Embolus (CFE): A Rare Cause of Multifocal Infarctions with Potential for Full Recovery	Disclosure: Dr. Taylor has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	005	Two Cases of Spinal Muscular Atrophy due to Mutations in the VRK1 Gene	Disclosure: Dr. Sung has nothing to disclose.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	005	Age Norms of EEG during Sleep from 0 to 100 years old	Disclosure: Dr. Paixao has nothing to disclose.
Neuroepidemiology: ALS, MS, Parkinson's Disease and Epilepsy
Start Time	Pub.	Title	Presenter
11:30 AM	005	An Analysis of Free-text Responses by Individuals Enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry	Disclosure: Dr. Jordan has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	005	Neural Responses Are Abnormal During Reflexive Blinking in Blepharospasm: An Event-Related fMRI Study	Disclosure: Dr. Nguyen has nothing to disclose.
NeuroHIV and other Retroviruses
Start Time	Pub.	Title	Presenter
11:30 AM	005	Neurofilament Light Chain Protein Levels in HIV Positive Subjects with Neuropathy	Disclosure: Dr. Damian has nothing to disclose.
Aging and Dementia: Clinical Trials
Start Time	Pub.	Title	Presenter
11:30 AM	006	A Multidomain Precision Medicine Intervention in Patients at Risk for Dementia due to Alzheimer’s disease	Disclosure: Dr. Isaacson has nothing to disclose.
Movement Disorders ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	006	STN LFP and SUA characterization of dyskinesia in PD using microelectrode recordings	Disclosure: Dr. Jimenez Shahed has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with St. Jude Medical/Abbott, Medtronic, Boston Scientific, Teva, Bracket,Nuvelution, Sunovion,. Dr. Jimenez Shahed has received research support from Medtronic, St. Jude Medical/Abbott, Lily, Wilsons Therapeutics, Sunovion, Nuvelution.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	006	OnabotulinumtoxinA wear-off phenomenon in the treatment of chronic migraine	Disclosure: Dr. Masters-Israilov has nothing to disclose.
Check Point Inhibitors and Paraneoplastic Neurological Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	006	Hunting the real culprit: a complex case of nivolumab-related myelitis.	Disclosure: Dr. Poretto has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	006	Tip-of-the-Basilar Stroke secondary to Fat Embolization after Hip Arthroplasty	Disclosure: Dr. Gopal has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	006	Oculomotor Dysfunction in Motor Neuron Disease	Disclosure: Dr. Lu has nothing to disclose.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	006	EEG Source Imaging from Standard Long-term Video EEG Recording in Patients with Medically-refractory Focal Epilepsy	Disclosure: Dr. Cox has nothing to disclose.
Neuroepidemiology: ALS, MS, Parkinson's Disease and Epilepsy
Start Time	Pub.	Title	Presenter
11:30 AM	006	PRO-ACE: Global Collaborative Ecosystem in a Post-PRO-ACT Era	Disclosure: Dr. Sherman has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	006	Wireless, Wearable, Soft Electronics for Blepharospasm Assessment	Disclosure: Dr. Scorr has nothing to disclose.
NeuroHIV and other Retroviruses
Start Time	Pub.	Title	Presenter
11:30 AM	006	Inhibiting Mononuclear Phagocyte Functions in a HIV Associated Neurocognitive Disorders Mouse Model	Disclosure: Dr. Tyor has nothing to disclose.
Aging and Dementia: Clinical Trials
Start Time	Pub.	Title	Presenter
11:30 AM	007	Efficacy of Memantine Added to Cholinesterase Inhibitors on SIB Higher-Order Cognitive Domains: Pooled Post Hoc Analysis of 2 Randomized Controlled Trials in Patients With Moderate to Severe AD	Disclosure: Dr. Schmitt has received research support from NIH.
Movement Disorders ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	007	Gender disparities in deep brain stimulation surgery for Parkinson’s disease	Disclosure: Dr. Garbin Di Luca has nothing to disclose.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	007	'Sleep Disturbance and Environmental Reactivity as Potential Mechanisms for Comorbidity of Mood and Anxiety Disorders with Migraine	Disclosure: Dr. Lateef has nothing to disclose.
Check Point Inhibitors and Paraneoplastic Neurological Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	007	Pembrolizumab-Induced Myasthenia Gravis	Disclosure: Dr. ALGaeed has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	007	Erythrocytapheresis: An emerging treatment option for cerebral fat embolism from hemoglobinopathy related bone marrow necrosis.	Disclosure: Dr. Siddiqui has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	007	Observational Quantitative Data in Adult Patients with SMA Dosed with Nusinersen	Disclosure: Dr. Burian has nothing to disclose.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	007	Longitudinal Analysis of Interictal EEGs in Patients with TLE and Hippocampal Sclerosis	Disclosure: Dr. Brito has nothing to disclose.
Neuroepidemiology: ALS, MS, Parkinson's Disease and Epilepsy
Start Time	Pub.	Title	Presenter
11:30 AM	007	Forecasting Multiple Sclerosis Hospitalization and Healthcare Burden in the United States from 2017 to 2040	Disclosure: Dr. Sharma has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	007	Golfer’s Cramp: Effect of Propranolol and Looking at the Hole	Disclosure: Dr.Adler has received personal compensation for consulting serving on a scientific advisory board speaking or other activities with Acadia Jazz Neurocrine Scion and Sunovion.
NeuroHIV and other Retroviruses
Start Time	Pub.	Title	Presenter
11:30 AM	007	Occurrence of pneumocystis pneumonia in patients with neurological disease on immunosuppression: a single-center investigation	Disclosure: Dr. Li MD has nothing to disclose.
Aging and Dementia: Clinical Trials
Start Time	Pub.	Title	Presenter
11:30 AM	008	SIB Maintenance of Response With Memantine Added to Cholinesterase Inhibitors: Pooled Post Hoc Analysis of 2 Randomized Controlled Trials in Patients With Moderate to Severe AD	Disclosure: Dr. Schmitt has received research support from NIH.
Movement Disorders ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	008	Hyperglycemic Induced Chorea-Ballismus Responsive to Valbenazine: a Video Case Report and Review of the Literature.	Disclosure: Dr. Saunders has nothing to disclose.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	008	Methylation Analyses of Stress-Modified Genes in Migraine	Disclosure: Dr. Oterino Duran has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, Almirall, Merck Serono, TEVA, Sanofi Genzyme, Allergan, MSD and Novartis. Dr. Oterino Duran has received research support from Sanofi Genzyme, Novartis.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	008	NFL pattern in progressive Multiple Sclerosis cohort under MD1003 treatment	Disclosure: Dr. Pignolet has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	008	Delayed Diagnosis of Fibrocartilaginous Embolism: Assessing the Vertebral Body on MRI	Disclosure: Dr. Isaac has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	008	Feasibility and Validation of Modified Oculobulbar Facial Respiratory Score (mOBFRS) in Amyotrophic Lateral Sclerosis	Disclosure: Dr. Goyal has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acceleron, Alexion, CSL Behring, MT Pharma.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	008	Quantitative EEG of Intracranial Recordings for Detection of Seizure Onset and Localization Compared to Standard Intracranial Tracing	Disclosure: Dr. Gangloff has nothing to disclose.
Neuroepidemiology: ALS, MS, Parkinson's Disease and Epilepsy
Start Time	Pub.	Title	Presenter
11:30 AM	008	Effects of cigarette smoking and smoking cessation on Multiple Sclerosis severity: a cross-sectional study	Disclosure: Dr. Ivashynka has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	008	Hand Motor Control in Patients with Cervical Dystonia: an fMRI Study	Disclosure: Dr. Hok has nothing to disclose.
NeuroHIV and other Retroviruses
Start Time	Pub.	Title	Presenter
11:30 AM	008	Minimal Effect on Cognitive Function Despite High Prevalence of Mental Health Disorders in Treated HIV	Disclosure: Dr. Horne has nothing to disclose.
Aging and Dementia: Clinical Trials
Start Time	Pub.	Title	Presenter
11:30 AM	009	Sildenafil Alters Hippocampal Fractional Amplitude of Low Frequency Fluctuations (fALFF) in Patients with Alzheimer’s Disease	Disclosure: Dr. Samudra has nothing to disclose.
Movement Disorders ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	009	Gait Analysis of GBA Mutation Carriers with Parkinson’s Disease	Disclosure: Dr. Gera has nothing to disclose.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	009	Healthcare Expenditure in Migraine Compared to Other Leading Causes of Disability: Adequate or Not?	Disclosure: Dr. Schaetz has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novartis Pharma AG, Switzerland.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	009	Longitudinal stability of anti–JC virus (JCV) antibody index over 2 years in multiple sclerosis (MS) patients treated with natalizumab in the ASCEND study	Disclosure: Dr Mason is an employee of Biogen and receives personal compensation for employment. Dr Mason is an employee of Biogen and has received stock options from Biogen. Dr Mason is an employee and held stock in Biogen.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	009	CNS Manifestations of Hemophagocytic Lymphohistiocytosis (HLH)	Disclosure: Dr. Edwards has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	009	Monitoring and promoting effectiveness and adherence to non-invasive ventilation in motor neurone disease using EncoreAnywhere telemonitoring: a pilot and feasibility, randomised controlled trial.	Disclosure: Dr. James has nothing to disclose.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	009	Validation of a dry-electrode EEG recording system: Results of a multi-reader blinded comparison to standard EEG	Disclosure: Dr. Zarroli has nothing to disclose.
Neuroepidemiology: ALS, MS, Parkinson's Disease and Epilepsy
Start Time	Pub.	Title	Presenter
11:30 AM	009	An increase in the prevalence of Multiple Sclerosis has moved Kuwait to a high-risk zone	Disclosure: Dr. Alroughani has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Bayer, Biogen, Biologix, Merck, Novartis, Roche and Sanofi. Dr. Alroughani has received research support from Biogen, Merck, Novartis, Roche and Sanofi.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	009	Cervical dystonia patient’s satisfaction level after 3 years of botulinum toxin treatment	Disclosure: Dr. Misra has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Ipsen Pharma.
NeuroHIV and other Retroviruses
Start Time	Pub.	Title	Presenter
11:30 AM	009	Inflammatory HIV-associated progressive multifocal leukoencephalopathy associated with high CD4 count	Disclosure: Dr. Ding has nothing to disclose.
Aging and Dementia: Clinical Trials
Start Time	Pub.	Title	Presenter
11:30 AM	010	Metformin and Newer Oral Hypoglycemic Agents are Associated with Better Cognitive Test Performance Over Ten Years in Older Diabetic Men	Disclosure: Dr. Duarte has nothing to disclose.
Movement Disorders ePoster Session
Start Time	Pub.	Title	Presenter
11:30 AM	010	Changes to Levodopa Daily Dose in Parkinson’s Disease (PD) Patients with Dyskinesia While on GocovriTM (Amantadine) Extended Release Capsules: a Two-Year Phase 3 Open Label Study Analysis	Disclosure: Dr. Isaacson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Abbvie, Acadia, Acorda, Adamas, Addex, Allergan, Amarantus, Avid, Axovant, AZTherapies, Biogen, Britannia, Eisai, Eli Lilly, Enterin, GE Healthcare, Impax, Intec Pharma, Ipsen, Kyowa, Lundbeck, Michael J. Fox Foundation, Neurocrine, NeuroDerm, NINDS/NIH, Parkinson Study Group, Pfizer, Pharma Two B, Roche, Sanofi, Sunovion, Teva, UCB, US WorldMeds, and Zambon. Dr. Isaacson has received research support from Abbvie, Acadia, Acorda, Adamas, Amarantus, Axovant, AZ Therapies, Benevolent, Biogen, Cavion, Eli Lilly, Enterin, Impax, Intec Pharma, Jazz, Ipsen, Kyowa, Lundbeck, Michael J. Fox Foundation, Neuroderm, Parkinson Study Group, Pfizer, Pharma2B, Roche, Sanofi, Sunovion, Teva, UCB, US WorldMeds.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	010	Message Framing to Determine Best Methods for Discussing Migraine Behavioral Treatments with Persons with Migraine.	Disclosure: Dr. Jalloh has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	010	Two Cases of Meningitis Associated with Ocrelizumab Therapy	Disclosure: Dr. Theriault has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	010	Secondary Polycythemia as an Uncommon Cause of Large Vessel Occlusion Resulting in Acute Ischemic Stroke	Disclosure: Dr. Mulpur has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	010	Accelerated Pathology in Chlorovirus (ATCV-1) Infected SOD1G93A Transgenic ALS Mice and Association of Increased Serum Anti-ATCV-1 IgG1 Subclass with ALS	Disclosure: Dr. Pattee has nothing to disclose.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	010	Surface-Electromyography (sEMG) Patterns of Clonic Bursts during Generalized Tonic-Clonic (GTC) Seizures	Disclosure: Dr. Cardenas has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Brain Sentinel.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	010	Basal Ganglia and Cerebellar Circuits Have Distinct Roles in Blepharospasm	Disclosure: Dr. Glickman has nothing to disclose.
NeuroHIV and other Retroviruses
Start Time	Pub.	Title	Presenter
11:30 AM	010	Thrombotic thrombocytopenic purpura (TTP) presenting with severe neurological manifestations in a patient with well-controlled HIV-1	Disclosure: Dr. Kimbrough has nothing to disclose.
Aging and Dementia: Clinical Trials
Start Time	Pub.	Title	Presenter
11:30 AM	011	Long-Term Efficacy for Parkinsonism and Safety of Zonisamide in Patients with Dementia with Lewy Bodies: A Phase III Trial	Disclosure: Dr. Toya has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sumitomo Dainippon Pharma Co., Ltd.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	011	A Randomized Controlled Trial to Assess the Effect of Telephone Based Motivational Interviewing on the Initiation and Adherence to Behavioral Therapy for Migraine	Disclosure: Dr. Minen has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	011	Fingolimod related cryptococcal meningitis and immune reconstitution inflammatory syndrome in two patients with multiple sclerosis	Disclosure: Dr. Cuascut Lassus has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	011	Multiterritorial ischemic strokes in idiopathic hypereosinophilic syndrome	Disclosure: Dr. Lee has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	011	Brain White Matter MRI Differentiates Kennedy’s Disease from Other Motor Neuron Disease Clinical Phenotypes	Disclosure: Dr. Spinelli has nothing to disclose.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	011	In the kingdom of triphasic waves, white matter is the eminence grise	Disclosure: Dr. Kotchetkov has nothing to disclose.
Neuroepidemiology: ALS, MS, Parkinson's Disease and Epilepsy
Start Time	Pub.	Title	Presenter
11:30 AM	011	Lewy body dementia (LBD) prevalence and cholinesterase inhibitor use in Florida	Disclosure: Dr. Patel has nothing to disclose.
NeuroHIV and other Retroviruses
Start Time	Pub.	Title	Presenter
11:30 AM	011	Immune Reconstitution Inflammatory Syndrome in a newly diagnosed patient with HIV and Central Nervous System Tuberculosis (TB)	Disclosure: Dr. Abu-hadid has nothing to disclose.
Aging and Dementia: Clinical Trials
Start Time	Pub.	Title	Presenter
11:30 AM	012	Long-term Efficacy of Zonisamide on Parkinsonism in Dementia with Lewy Bodies: A Post-hoc Analysis of Phase 3 Trial	Disclosure: Dr. Takai has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sumitomo Dainippon Pharma Co., Ltd.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	012	Exploring Natural Cohorts of Chronic Migraine Phenotype	Disclosure: Dr. Woldeamanuel has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	012	Leprosy in two patients with Relapsing Remitting Multiple Sclerosis (RRMS) treated with Fingolimod	Disclosure: Dr. Balasa has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	012	Acute Ischemic Stroke in Cancer Patients. A Case-Control Study	Disclosure: Dr. Pappolla has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	012	Nusinersen for spinal muscular atrophy - results of an expanded access programme	Disclosure: Dr. Mazurkiewicz Beldzin has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen Biomarin.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	012	Diagnostic Utility of Continuous sEMG Monitoring in a Home Setting - Real-world use of the SPEAC® System	Disclosure: Dr. Whitmire has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Brain Sentinel.
Neuroepidemiology: ALS, MS, Parkinson's Disease and Epilepsy
Start Time	Pub.	Title	Presenter
11:30 AM	012	Vision loss in Parkinson’s disease: prevalence and association with outcomes among Medicare beneficiaries	Disclosure: Dr. Hamedani has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	012	Immunogenicity of DaxibotulinumtoxinA for Injection in Adults with Cervical Dystonia from a Phase 2 Dose-Escalation Multicenter Study	Disclosure: Dr. Brashear has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Ipsen and Revance. Dr. Brashear has received research support from Wake Forest.
NeuroHIV and other Retroviruses
Start Time	Pub.	Title	Presenter
11:30 AM	012	PML presenting as an isolated vertigo: a diagnositic challange	Disclosure: Dr. Moustafa has nothing to disclose.
Aging and Dementia: Clinical Trials
Start Time	Pub.	Title	Presenter
11:30 AM	013	Transcranial Direct Current Stimulation Improves Verbal Fluency in Patients with Primary Progressive Aphasia	Disclosure: Dr. Hosseini has nothing to disclose.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	013	Risk of Worse Short-term Outcomes Associated with hospitalization for migraine and co-morbid psychiatric illness: A Nationwide Population-Based Cohort Study	Disclosure: Dr. Savani has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	013	Dimethyl Fumarate Dose Reduction in Lymphopenic Relapsing Remitting Multiple Sclerosis Patients: Clinical and MRI Outcomes	Disclosure: Dr. Wong has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	013	Prudent testing of factor V Leiden in Ischemic stroke	Disclosure: Dr. Kovi has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	013	Fat mass loss correlates with survival in amyotrophic lateral sclerosis patients: prospective cohort study	Disclosure: Dr. Lee has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Alexion.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	013	Is There a Role for Magnetoencephalography in Pre-surgical RNS Implantation in Drug-Resistant Temporal Lobe Epilepsy?	Disclosure: Dr. Alshammaa has nothing to disclose.
Neuroepidemiology: ALS, MS, Parkinson's Disease and Epilepsy
Start Time	Pub.	Title	Presenter
11:30 AM	013	Risk of readmission for injury in patients with epilepsy in the US	Disclosure: Dr. Goldstein has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	013	Implementation of the current dystonia classification from 2013 to 2017	Disclosure: Dr. Albanese has nothing to disclose.
NeuroHIV and other Retroviruses
Start Time	Pub.	Title	Presenter
11:30 AM	013	An Unusual Case of Multiple-Ring-Enhancing Lesions on Brain MRI in Varicella Zoster Virus Encephalitis	Disclosure: Dr. Hasan has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	014	Hepatitis E virus infection and posterior reversible encephalopathy syndrome: a case report and review of the literature.	Disclosure: Dr. Loggini has nothing to disclose.
Aging and Dementia: Clinical Trials
Start Time	Pub.	Title	Presenter
11:30 AM	014	Safety and Efficacy of Medical Cannabis in Elderly Patients: A Retrospective Review in a Neurological Outpatient Setting.	Disclosure: Dr. Bargnes has received research support from Dent Family Foundation.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	014	Angiotensin Receptor Blockers and ACE Inhibitors for Migraine Prophylaxis - A Systematic Review	Disclosure: Dr. Dorosh has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	014	Infectious Risk Stratification in Multiple Sclerosis Patients Receiving Immunotherapy – An Update	Disclosure: Dr. Graf has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	014	An Uncommon Cause of Multifocal Intracerebral Hemorrhages: Adult-Onset Leukoencephalopathy with Calcifications and Cysts	Disclosure: Dr. Pyatka has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	014	Validation of a staging system in ALS: Comparison of the US and European Populations	Disclosure: Dr. Kwan has nothing to disclose.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	014	Glossokinetic Potentials: Insights from intracranial EEG	Disclosure: Dr. Kacar Bayram has nothing to disclose.
Neuroepidemiology: ALS, MS, Parkinson's Disease and Epilepsy
Start Time	Pub.	Title	Presenter
11:30 AM	014	Characteristics of periventricular nodules in patients with 22q11. 2 deletion syndrome	Disclosure: Dr. Rezazadeh has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	014	A dopa-responsive dystonia-Parkinsonism-cerebellar syndrome associated with GCH1 gene mutation.	Disclosure: Dr. Garrett has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	015	Abulia: A case of Powassan Encephalitis	Disclosure: Dr. Yalcin has nothing to disclose.
Aging and Dementia: Clinical Trials
Start Time	Pub.	Title	Presenter
11:30 AM	015	Intranasal Glulisine in Down Syndrome: A Pilot Safety and Tolerability Trial	Disclosure: Dr. Rosenbloom has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Paul Weiss. Dr. Rosenbloom has received research support from Merck Foundation.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	015	Effect of Galcanezumab on Severity of Headache and Associated Symptoms of Migraine in Phase 3 Trials in Patients with Episodic or Chronic Migraine	Disclosure: Dr. Day has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Employee of Eli Lilly and Company.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	015	Evaluating the Tolerability and Safety of Switching from Rituximab to Ocrelizumab: Infusion Related Reactions in Relapsing Forms of Multiple Sclerosis	Disclosure: Dr. Alvarez has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with consulting fees from Actelion, Bayer, Biogen, Celgene, EMD Serono, Genentech, Genzyme, Novartis, and TG Therapeutics. Dr. Alvarez has received research support from Biogen, Genentech, Novartis, TG Therapeutics, and Rocky Mountain MS Center.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	015	Lacunar Strokes in Cryptococcal Meningitis: Clinical and Radiographic Features in a U.S. Cohort	Disclosure: Dr. Vela-Duarte has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	015	Nusinersen in Adults with Spinal Muscular Atrophy, A Single Center Experience	Disclosure: Dr. Moshe-Lilie has nothing to disclose.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	015	Ictal urinary urgency localized by Stereo-electroencephalogram.	Disclosure: Dr. Murray-Frank has nothing to disclose.
Neuroepidemiology: Stroke, Critical Care, Headache and Global Health
Start Time	Pub.	Title	Presenter
11:30 AM	015	Cognitive decline after a mild or moderate stroke and TIA: evidence from the SWIFT Trial	Disclosure: Dr. Boden-Albala has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	015	Assessment of standing balance by force plate posturography in X-linked Dystonia Parkinsonism (XDP)	Disclosure: Dr. Stephen has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	016	West Nile encephalitis in a patient with initially negative CSF serology.	Disclosure: Dr. Sanmartin has nothing to disclose.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	016	Migraine and Cluster Headache Classification Using a Supervised Machine Learning Approach: A Multimodal MRI Study	Disclosure: Dr. Messina has nothing to disclose.
Aging and Dementia: Neuropsychology and Clinical Studies II
Start Time	Pub.	Title	Presenter
11:30 AM	016	Structured delirium care pathway is associated with reductions in length of stay, cost and readmissions in hospitalized adults	Disclosure: Dr. LaHue has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	016	A Rare Complication of Fingolimod: Case Report of Posterior Reversible Encephalopathy Syndrome	Disclosure: Dr. Downey Allison has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	016	Hypertension Increases Risk of Ischemic Stroke in Multiple Sclerosis: Retrospective Analysis of a National Database	Disclosure: Dr. Ikram has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	016	Spinal Muscular Atrophy: A Review of Epidemiology, Burden and Unmet Needs	Disclosure: Dr. Callan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novartis Ireland Ltd.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	016	The Prognostic Value of Quantitative EEG in Patients Undergoing Mechanical Thrombectomy for Acute Ischemic Stroke	Disclosure: Dr. Dickey has nothing to disclose.
Neuroepidemiology: Stroke, Critical Care, Headache and Global Health
Start Time	Pub.	Title	Presenter
11:30 AM	016	Seasonal Variation in Stroke Incidence in Black versus White Medicare Beneficiaries	Disclosure: Dr. Baig has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	016	Botulinum toxin injection changes resting state cerebellar connectivity in cervical dystonia.	Disclosure: Dr. Nevrly has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with consultant for Medtronic.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	017	A Bird Whisperer’s Tale: The unique occurrence of stroke as a precursor to diagnosing West Nile Meningoencephalitis.	Disclosure: Dr. Jacob has nothing to disclose.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	017	Acute Anti-Migraine Prescription Varies According to Baseline Cardiovascular Risk and Clinical Characteristics: A Real-World Evidence Study	Disclosure: Dr. Li has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eli Lilly and Company. Dr. Li holds stock and/or stock options in Eli Lilly and Company.
Aging and Dementia: Neuropsychology and Clinical Studies II
Start Time	Pub.	Title	Presenter
11:30 AM	017	Snow laughing matter: Delirium severity increases in winter months compared with summer months	Disclosure: Dr. Douglas has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	017	Among Real-world Multiple Sclerosis Patients That Experience Delayed-release Dimethyl Fumarate-associated Lymphopenia, Meaningful Lymphocyte Reconstitution Occurs Approximately 3 Months After Discontinuation of Delayed-release Dimethyl Fumarate	Disclosure: Dr. Rose has received research support from National Multiple Sclerosis Society, Guthy Jackson Foundation, NIH, Friends of MS, Western Institute for Biomedical Research, and Biogen.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	017	Fabry disease and Stroke: Effectiveness of Enzyme Replacement Therapy (ERT) in Stroke Prevention, a Review with Meta-Analysis	Disclosure: Dr. Sheng has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	017	Determinants of Mortality Among Hospitalized Patients with Amyotrophic Lateral Sclerosis – Results from the 2016 National Inpatient Sample	Disclosure: Dr. L'Italien has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biohaven Pharmaceuticals. Dr. L'Italien holds stock and/or stock options in Biohaven Pharmaceuticals which sponsored research in which Dr. L'Italien was involved as an investigator. Dr. L'Italien holds stock and/or stock options in Biohaven Pharmaceuticals. Dr. L'Italien has received research support from Biohaven Pharmaceuticals.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	017	Wearable Sensors for the Detection of Convulsive Seizures	Disclosure: Dr. McGinn has nothing to disclose.
Neuroepidemiology: Stroke, Critical Care, Headache and Global Health
Start Time	Pub.	Title	Presenter
11:30 AM	017	Disparities, Predictors and Trends of Left Atrial Appendage Closure Among Hospitalized Patients with Atrial Fibrillation in the United States	Disclosure: Dr. Badi has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	017	Jaw Opening Oromandibular Dystonia following Acute Stroke: Analysis and Review	Disclosure: Dr. Singhvi has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	018	Case Series: Congenital Zika Virus Infection associated with Epileptic Spasms	Disclosure: Dr. Diaz Diaz has nothing to disclose.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	018	Work Activities Associated with Migraine: Results from Migraine in America Symptoms and Treatment (MAST) Study	Disclosure: Dr. Alam has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Dr. Reddy’s Laboratories group of companies.
Aging and Dementia: Neuropsychology and Clinical Studies II
Start Time	Pub.	Title	Presenter
11:30 AM	018	Identifying Common Themes in ICU Deaths of Patients with a Diagnosis of Alzheimer Disease	Disclosure: Dr. Grant has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	018	No significant risk of malignant melanoma growth under cladribine treatment: in vitro studies	Disclosure: Dr. Berestjuk has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	018	Sickle Cell Trait and Risk for Early-Onset Ischemic Stroke	Disclosure: Dr. Zhang has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	018	Analysis of nutritional status as a predictor of survival in patients with bulbar amyotrophic lateral sclerosis (ALS)	Disclosure: Dr. Bettini has nothing to disclose.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	018	The Use of Collodion versus Traditional Paste for Reducing Artifact in Ambulatory Electroencephalography Studies in the Pediatric Population	Disclosure: Dr. Brigham has nothing to disclose.
Neuroepidemiology: Stroke, Critical Care, Headache and Global Health
Start Time	Pub.	Title	Presenter
11:30 AM	018	Comparing the Outcomes of Patients with Idiopathic Subarachnoid Hemorrhage by Three Distinct Perimesencephalic Bleed Patterns	Disclosure: Dr. Wagner has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	018	ATP1A3 Gene Mutations Associated with Rapid-Onset Dystonia-Parkinsonism (RDP) Presenting with Functional Neurologic Disorder: A Report of Two Cases	Disclosure: Dr. Biller has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	019	The Diagnosis of Pseudorabies Virus Encephalitis and Endophthalmitis by Next Generation Sequencing in Two Chinese Pork Retailers	Disclosure: Dr. Liu has nothing to disclose.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	019	Triptan Use and Discontinuation in a Representative Sample of Persons With Migraine: Results From Migraine in America Symptoms and Treatment (MAST) Study	Disclosure: Dr. Alam has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Dr. Reddy’s Laboratories group of companies.
Aging and Dementia: Neuropsychology and Clinical Studies II
Start Time	Pub.	Title	Presenter
11:30 AM	019	Caregiver Depression and Emergency Department Utilization in Dementia	Disclosure: Dr. Guterman has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	019	Serious Adverse Events in Rituximab-Treated Patients with Multiple Sclerosis and Related Disorders	Disclosure: Dr. Wallach has received research support from Biogen.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	019	Degos' disease: the hint is in the skin	Disclosure: Dr. Calame has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	019	Dextromethorphan-Quinidine (Nuedexta) Improves Swallowing in Bulbar Onset ALS Patients with Pseudobulbar Affect - Pre-Post Observational Study in 86 ALS Patients	Disclosure: Dr. Shah has nothing to disclose.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	019	An Effective Tool for Teaching EEG Interpretation to Residents and Medical Students	Disclosure: Dr. Hubert has nothing to disclose.
Neuroepidemiology: Stroke, Critical Care, Headache and Global Health
Start Time	Pub.	Title	Presenter
11:30 AM	019	Time Trends, Race Disparities, and Administration of Intravenous Thrombolysis for Acute Ischemic Stroke: A Statewide Study	Disclosure: Dr. Marszalek has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	019	Pilot trial of botulinum toxin and occupational therapy for Writer’s Cramp	Disclosure: Dr. Park has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	020	An unusual case of feline-transmitted Rabies: A Diagnostic and Preventative Approach.	Disclosure: Dr. Escobar-Montealegre has nothing to disclose.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	020	Prophylactic Use of SNRIs to Treat Pediatric Migraine via Reduction of Comorbid Anxiety and Depression	Disclosure: Dr. McAlister has nothing to disclose.
Aging and Dementia: Neuropsychology and Clinical Studies II
Start Time	Pub.	Title	Presenter
11:30 AM	020	The Lived Experience of Lay Caregivers Caring for Persons with Dementia	Disclosure: Dr. Mayo has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	020	Central Nervous System T Cell Lymphoproliferative Disease Following Treatment with Alemtuzumab	Disclosure: Dr. Horton has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	020	Diagnostic Challenges in Vascular Myelopathies	Disclosure: Dr. Passeri has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	020	Structural and Functional Organization of the Brain Connectome in Patients with Different Motor Neuron Diseases: A Multicenter Study	Disclosure: Dr. Agosta has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novartis.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	020	Case Report: Change in Electrocorticogram Detection of RNS with Initiation of Ketogenic Diet	Disclosure: Dr. Greenwood has nothing to disclose.
Neuroepidemiology: Stroke, Critical Care, Headache and Global Health
Start Time	Pub.	Title	Presenter
11:30 AM	020	For Men Only, High Hematocrit Values Are Associated With Stroke In The Young	Disclosure: Dr. Bartt has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	020	Identifying Reliable Measures of Impairment in Focal Hand Dystonia Patients	Disclosure: Dr. Bukhari-Parlakturk has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	021	An Uncommon Case of Treatment-Responsive SSPE	Disclosure: Dr. Hocquard has nothing to disclose.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	021	Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene?Related Peptide Receptor	Disclosure: Dr. Moore has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck & Co., Inc. Dr. Moore holds stock and/or stock options in Merck & Co., Inc which sponsored research in which Dr. Moore was involved as an investigator.
Aging and Dementia: Neuropsychology and Clinical Studies II
Start Time	Pub.	Title	Presenter
11:30 AM	021	Real World Treatment of Parkinson’s Disease Dementia (PDD) in the United States (U.S.)	Disclosure: Dr. Schroeder has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Eli Lilly and Company. Dr. Schroeder holds stock and/or stock options in Eli Lilly and Company which sponsored research in which Dr. Schroeder was involved as an investigator. .
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	021	Risk factors for Development of Lymphopenia in Dimethyl Fumarate-treated Patients with Multiple Sclerosis	Disclosure: Dr. Bloch has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	021	Isolated Cervical Anterior Spinal Artery Aneurysms (CASAAs): A Case Series and The Comprehensive Outcome Analysis of surgical vs non-surgical interventions	Disclosure: Dr. SirDeshpande has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	021	CX3CL1 Disruption Differentially Influences the Neuroprotective Effects of Mesenchymal Stromal Cells on ALS	Disclosure: Dr. Huang has nothing to disclose.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	021	Correlation of Indicators of P300 Cognitive Potentials with Epilepsy Forms	Disclosure: Dr. Salokhiddinov has nothing to disclose.
Neuroepidemiology: Stroke, Critical Care, Headache and Global Health
Start Time	Pub.	Title	Presenter
11:30 AM	021	Systematic Characterization of Large Vessel Occlusion Strokes at a CSC	Disclosure: Dr. Desai has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	021	Indications, Outcomes and Cost of pediatric Deep Brain Stimulation Surgeries in the United States: An Analysis of the Kids’ Inpatient Sample	Disclosure: Dr. Akano has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	022	West Nile Virus Neuroinvasive Disease Associated with Rituximab Therapy	Disclosure: Dr. Owens has nothing to disclose.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	022	Response to Lasmiditan for Acute Treatment of Migraine Based on Prior Response to Triptan Therapy	Disclosure: Dr. Knievel has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Consulting for Amgen, Lilly, Allergan, Biohaven. Speaking Amgen and Allergan.. Dr. Knievel has received research support from Allergan; Alder.
Aging and Dementia: Neuropsychology and Clinical Studies II
Start Time	Pub.	Title	Presenter
11:30 AM	022	MCI and OSA	Disclosure: Dr. Patel has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	022	Severe skin reactions associated with Cladribine treatment in patients with multiple sclerosis	Disclosure: Dr. Mateo-Casas has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with UCB Pharma, Sanofi-Genzyme.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	022	Intravascular Lymphoma Presenting with Spinal Cord Infarct and Recurrent Ischemic Strokes	Disclosure: Dr. Lyden has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	022	Adherence to Riluzole Therapy Improves Time to and Frequency of All Cause Hospitalization in ALS Patients: A Claims-Based Longitudinal Comparative Effectiveness Analysis.	Disclosure: Dr. L'Italien has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biohaven Pharmaceuticals. Dr. L'Italien holds stock and/or stock options in Biohaven Pharmaceuticals which sponsored research in which Dr. L'Italien was involved as an investigator. Dr. L'Italien holds stock and/or stock options in Biohaven Pharmaceuticals. Dr. L'Italien has received research support from Biohaven Pharmaceuticals.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	022	Assessing Retinal Cytoarchitecture between Temporal Onset Focal and Primary Generalized Seizure Types Utilizing Optical Coherence Tomography	Disclosure: Dr. Lichtman-Mikol has nothing to disclose.
Neuroepidemiology: Stroke, Critical Care, Headache and Global Health
Start Time	Pub.	Title	Presenter
11:30 AM	022	Is Altitude Associated With Ischemic Stroke In The Young?	Disclosure: Dr. Salottolo has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	022	Kufor-Rakeb Syndrome with Prominent Dystonia and New Mutations in ATP13A2 Gene in Two Siblings	Disclosure: Dr. Yamasaki has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	023	A Quality Improvement Project Studying the Integration of a Proposed Diagnostic Algorithm on Inpatient Encephalitis into the Electronic Medical Record and its Impact on Length of Hospital Stay	Disclosure: Dr. Kaplan has nothing to disclose.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	023	Impact of OnabotulinumtoxinA on Quality of Life, Health Resource Utilization, and Work Productivity in People With Chronic Migraine: Interim Results From a Prospective, Observational Study (PREDICT)	Disclosure: Dr. Boudreau has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Allergan, Amgen, Lilly, and Teva. Dr. Boudreau has received research support from Allergan, Amgen, Lilly, and Teva.
Aging and Dementia: Neuropsychology and Clinical Studies II
Start Time	Pub.	Title	Presenter
11:30 AM	023	Vascular dementia in elderly .Population-based study in Matanzas.	Disclosure: Dr. Munoz Perez has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	023	Delayed-release Dimethyl Fumarate-associated Lymphopenia: On-treatment and Post-treatment Implications	Disclosure: Dr. Chan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Bayer, Biogen, Genzyme, Merck, Novartis, Roche, Teva, Swiss National Fonds, Genzyme and UCB, Clinical and translational neuroscience and the Journal of International medical research. Dr. Chan has received research support from Bayer, Biogen, Genzyme, Merck, Novartis, Roche, Teva, Swiss National Fonds, Genzyme and UCB, Clinical and translational neuroscience and the Journal of International medical research.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	023	Simultaneous Epidural and Intramedullary Hemorrhage: A Case Report.	Disclosure: Dr. Shah has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	023	Diffusion Tension Imaging as the Biomarker for Amyotrophic Lateral Sclerosis	Disclosure: Dr. Baek has nothing to disclose.
Epilepsy: EEG and Neurophysiology
Start Time	Pub.	Title	Presenter
11:30 AM	023	Normalized transfer entropy used as an informational transfer measure of ictal pathophysiology in patients undergoing stereo-EEG for epilepsy surgery	Disclosure: Dr. Lee has received research support from America Epilepsy Society.
Neuroepidemiology: Stroke, Critical Care, Headache and Global Health
Start Time	Pub.	Title	Presenter
11:30 AM	023	Acute neurological complications after adult single and double lung transplant	Disclosure: Dr. Rauf has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	023	The Trend in Botulinum Toxin Injection among Medicare Neurology Providers in the United States from 2012 to 2016	Disclosure: Dr. Miri has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	024	A simple bioinformatics approach to disentangle the etiology and prognosis of CNS infections	Disclosure: Dr. Tan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novartis, Merck, UCB, Sanofi Genzyme and Eisai.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	024	Eptinezumab Increases Days Free from Canonical Migraine-Associated Symptoms Within 1 Month of Treatment in Patients with Chronic Migraine	Disclosure: Dr. Schim has received personal compensation from the following companies: Consultant: Acorda, Alder, Allergan, Amgen, Avanir, Depomed, electroCore, Lilly, Novartis, Pernix, Promius, Supernus, Teva, Upsher-Smith Grant/research support: Alder, Allergan, Amgen, electroCore, Lilly, Teva Speaker: Acorda, Allergan, Amgen, Avanir, Depomed, electroCore, Lilly, Novartis, Pernix, Promius, Supernus, Teva, Upsher-Smith Grant/research support: Alder, Allergan, Amgen, electroCore, Lilly, Teva
Aging and Dementia: Neuropsychology and Clinical Studies II
Start Time	Pub.	Title	Presenter
11:30 AM	024	Characteristics of Young-onset and Late-onset Dementia Patients at a Rural and Remote Memory Clinic	Disclosure: Dr. Wong has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	024	Immunization and Multiple Sclerosis: Recommendations from the French Multiple Sclerosis Society	Disclosure: Dr. Lebrun Frenay has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sanofi, Genzyme, Merck, Novartis, Biogen.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	024	Spinal Claudication Due to Anterior Disco-osteo-arterial Conflict Mimicking Stiff Person Syndrome	Disclosure: Dr. Murphy has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	024	Diminshed Muscle Oxygenation During Exercise in Ambulatory Spinal Muscular Atrophy Patients	Disclosure: Dr. Montes has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Astellas, Biogen, Cytokinetics, Roche, and Scholar Rock. Dr. Montes has received research support from MDA and NICHD / NIH.
Epilepsy: General Medical Issues, PNES, and Other
Start Time	Pub.	Title	Presenter
11:30 AM	024	The Relationship between Seizures, Ictal-Interictal EEG Activity, Clinical Outcome, and Dynamic Neurologic Changes following Traumatic Brain Injury	Disclosure: Dr. Edhi has nothing to disclose.
Neuroepidemiology: Stroke, Critical Care, Headache and Global Health
Start Time	Pub.	Title	Presenter
11:30 AM	024	Association between neurological syndromes and Arbovirus in Buenos Aires - Relationship between Guillain Barre Syndrome, Encephalitis and Myelitis with Zika, Dengue and Chikungunya	Disclosure: Dr. Kohler has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	024	RimabotulinumtoxinB (MYOBLOC) in the treatment of adult sialorrhea	Disclosure: Dr. Ondo has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with UCBPharma, TEVA, USWorldMeds, Neurocrine, ADAMAS. Dr. Ondo has received research support from Lundbeck, Sunovian, Neuroderm.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	025	Evaluation of BioFire Film Array Meningitis/ Encephalitis (ME) panel in testing of CSF specimen of patients of meningoencephalitis in Indian scenario	Disclosure: Dr. Rohatgi has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Abbott, Boehringer, Intas Pharma, Pfizer, Eisai, Genzyme, Sanofi, UCB, Cipla.
Migraine II
Start Time	Pub.	Title	Presenter
11:30 AM	025	Does the presence of Cranial Autonomic Symptoms in Chronic Migraine Patients Predict Efficacy of Botox Injections?	Disclosure: Dr. Riggins has nothing to disclose.
Aging and Dementia: Neuropsychology and Clinical Studies II
Start Time	Pub.	Title	Presenter
11:30 AM	025	Subjective Cognitive Impairment: A Clinical and neuropsychological Entity, sustained by a specific Topography of Lesions. The Cingulum Cohort of Marseille, France.	Disclosure: Dr. Sambuchi has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	025	Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis	Disclosure: Dr. Hauser has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Annexon, Symbiotix, Bionure and Neurona; he has also received travel reimbursement from F. Hoffmann-La Roche Ltd and Novartis for CD20-related meetings and presentation.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	025	Spinal Cord Infarction: A Diagnostic Challenge	Disclosure: Dr. Passeri has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	025	Population Based Surveillance and Survival Characteristics of Amyotrophic Lateral Sclerosis (ALS) Cases in the Atlanta Metropolitan Area, 2009 – 2011	Disclosure: Dr. Punjani MPH has nothing to disclose.
Epilepsy: General Medical Issues, PNES, and Other
Start Time	Pub.	Title	Presenter
11:30 AM	025	Seizures after Cardiovascular Surgery: An unexpected complication	Disclosure: Dr. Bolaño Diaz has nothing to disclose.
Neuroepidemiology: Stroke, Critical Care, Headache and Global Health
Start Time	Pub.	Title	Presenter
11:30 AM	025	Long-Term Outcomes of Guillain-Barre Syndrome Associated with Zika Virus Infection	Disclosure: Dr. Walteros has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	025	Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High Patient and Clinician Satisfaction in the ASPIRE Study	Disclosure: Dr. Francisco has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Allergan, Merz, and Ipsen. Dr. Francisco has received research support from Allergan, Merz, and Ipsen.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	026	Progressive Multifocal Leukoencephalopathy in an Immunocompetent Patient: A Rare Case with Radiologic-Pathologic Correlation	Disclosure: Dr. Fecto has nothing to disclose.
Aging and Dementia: Neuropsychology and Clinical Studies II
Start Time	Pub.	Title	Presenter
11:30 AM	026	The Free and Cued Selective Reminding Test Predicts Alzheimer’s Disease Neuropathology	Disclosure: Dr. Grober has received royalty, license fees, or contractual rights payments from Albert Einstein College of Medicine.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	026	Influence of Clinical and Cerebrospinal Fluid Parameters on the Effect of Therapeutic Plasma Exchange in Patients with Multiple Sclerosis	Disclosure: Dr. Eienbröker has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	026	CADASIL in a Patient with Bilateral Internal Carotid Artery Agenesis	Disclosure: Dr. MacDonald has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	026	Factors Associated with Poor Compliance of Non-invasive Ventilator Support in Patients with ALS	Disclosure: Dr. Kohli has nothing to disclose.
Epilepsy: General Medical Issues, PNES, and Other
Start Time	Pub.	Title	Presenter
11:30 AM	026	Prognosis and Clinical Factors to Predict Seizure Recurrence in Patients with Alcohol-Related Seizures	Disclosure: Dr. Chun has nothing to disclose.
Neuroepidemiology: Stroke, Critical Care, Headache and Global Health
Start Time	Pub.	Title	Presenter
11:30 AM	026	The Pattern of Neurologic Disease in Tanzanian Tribal Populations	Disclosure: Dr. Aamodt has nothing to disclose.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	026	Individualized OnabotulinumtoxinA Treatment for Lower Limb Spasticity Resulted in High Patient and Clinician Satisfaction in the ASPIRE Study	Disclosure: Dr. Esquenazi has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Allergan, Ipsen, and Mertz. Dr. Esquenazi has received research support from Allergan and Ipsen.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	027	A Case of Hepatitis E Transverse Myelitis	Disclosure: Dr. Doyle has nothing to disclose.
Aging and Dementia: Neuropsychology and Clinical Studies II
Start Time	Pub.	Title	Presenter
11:30 AM	027	Color Vision Impairment in Prodromal and Dementia Stages of Lewy Body Disease versus Alzheimer’s Disease	Disclosure: Dr. Unger has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	027	Cytomegalovirus (CMV) Primoinfection in a patient with Multiple Sclerosis treated with Alemtuzumab	Disclosure: Dr. Aguirre Hernandez has nothing to disclose.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	027	Rapidly progressive dementia with seizures due to venous hypertension from arteriovenous hemodialysis graft	Disclosure: Dr. Mazzola has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	027	Clinical Factors Predicting Cognitive Errors in The Misdiagnosis of Amyotrophic Lateral Sclerosis (ALS)	Disclosure: Dr. Gummi has nothing to disclose.
Epilepsy: General Medical Issues, PNES, and Other
Start Time	Pub.	Title	Presenter
11:30 AM	027	Acute Seizure Incidence in Ischemic Stroke Patients Treated with Mechanical retrieval therapy: A Single Center Study	Disclosure: Dr. Morris has nothing to disclose.
Neuroepidemiology: Stroke, Critical Care, Headache and Global Health
Start Time	Pub.	Title	Presenter
11:30 AM	027	Migraine and the Prevalence of Metabolic Syndrome among Women	Disclosure: Dr. Rist has received personal compensation in an editorial capacity for Stroke - a journal of the American Heart Association.
Dystonia and Botulinum Toxin Therapy
Start Time	Pub.	Title	Presenter
11:30 AM	027	Botulinum Toxin for the treatment of muscle spasms associated with Stiff Person Syndrome	Disclosure: Dr. Moukheiber has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	028	Neuroinvasive West Nile Virus: a Case Series in Nebraska	Disclosure: Dr. Purbaugh has nothing to disclose.
Aging and Dementia: Neuropsychology and Clinical Studies II
Start Time	Pub.	Title	Presenter
11:30 AM	028	The Role of Population Receptive Fields' Size in Understanding Complex Visual Dysfunctions: Posterior Cortical Atrophy Model	Disclosure: Dr. De Best has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	028	Changes in the immune cell profile in fingolimod-treated patients with relapsing multiple sclerosis: primary analysis of the FLUENT study	Disclosure: Dr. Mao-Draayer has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Accorda, Biogen, Bayer Pharmaceutical, Celgene, Teva, Genentech, Sanofi-Genzyme, Novartis, Chugai and EMD Serono. Dr. Mao-Draayer has received research support from NIH NIAID Autoimmune Center of Excellence, Sanofi-Genzyme, Novartis and Chugai.
Unusual Stroke Etiologies, Presentations and Treatments
Start Time	Pub.	Title	Presenter
11:30 AM	028	Recurrent Stroke in Giant Cell Arteritis Despite Immunotherapy	Disclosure: Dr. Cox has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	028	Facial Onset Sensory-Motor Neuronopathy: A Series of Two Cases Illustrating a Disease Spectrum	Disclosure: Dr. Yasin has nothing to disclose.
Epilepsy: General Medical Issues, PNES, and Other
Start Time	Pub.	Title	Presenter
11:30 AM	028	Postencephalitic Epilepsy and Acute Symptomatic Seizures, in Infectious, Undetermined Etiology and Autoimmune Encephalitis	Disclosure: Dr. Marone has nothing to disclose.
Child Neurology: Movement Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	028	Genetic testing of >1300 patients with cerebral palsy reveals an etiology in one-third of cases, underscoring the need for broad genetic testing and a significant recurrence risk for families.	Disclosure: Dr. Millan Zamora has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with GeneDx.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	028	Tremor in the Degenerative Cerebellum: Towards the Understanding of Brain Circuitry for Tremor	Disclosure: Dr. Kuo has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	029	West Nile Virus Encephalitis Associated with Intraventricular Diffusion Restriction	Disclosure: Dr. Shetty has nothing to disclose.
Aging and Dementia: Neuropsychology and Clinical Studies II
Start Time	Pub.	Title	Presenter
11:30 AM	029	Quantification of Real-World Life Space from Instrumented Vehicles in Drivers with Cognitive Aging	Disclosure: Dr. Merickel has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	029	Multiple sclerosis treatment strategy after natalizumab-associated progressive multifocal leukoencephalopathy	Disclosure: Dr. Waheed has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Vertebral and Basilar Artery Disease
Start Time	Pub.	Title	Presenter
11:30 AM	029	Outcomes of Mechanical Retrieval Therapy in Basilar Artery Occlusions: A Single Center Study	Disclosure: Dr. Hawkins has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	029	Frequency, Symptomology, and Course of HIV-Associated ALS: Case Series and Review	Disclosure: Dr. Satin has nothing to disclose.
Epilepsy: General Medical Issues, PNES, and Other
Start Time	Pub.	Title	Presenter
11:30 AM	029	Epilepsia Partialis Continua Secondary to Diabetic Ketoacidosis	Disclosure: Dr. Van Orman has nothing to disclose.
Child Neurology: Movement Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	029	Evalualuation of Tremor in Childhood Electrophysiologically Influences Prognosis and Outcome	Disclosure: Dr. Lavenstein has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	029	Cerebellar Structure in Patients with Parkinson’s Disease and Essential Tremor	Disclosure: Dr. Lopez has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	030	A Case of Presumed Post-Transplant West Nile Virus Encephalitis without CSF Pleocytosis or IgM Positivity	Disclosure: Dr. Shetty has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	030	Increased Multiple Sclerosis disease activity in patients transitioned from fingolimod to dimethyl fumarate	Disclosure: Dr. Delgado has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Vertebral and Basilar Artery Disease
Start Time	Pub.	Title	Presenter
11:30 AM	030	Outcomes of Acute Basilar Occlusion Ischemic Strokes with Advent of Modern Thrombectomy Devices, a New York State Experience	Disclosure: Dr. Vanguru has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	030	Primary Lateral Sclerosis (PLS) vs. Hereditary Spastic Paraperesis (HSP) in Presenilin-1 (PSEN1) related Dominant Dementia	Disclosure: Dr. Ahmadi Jazi has nothing to disclose.
Epilepsy: General Medical Issues, PNES, and Other
Start Time	Pub.	Title	Presenter
11:30 AM	030	Two Cases of Provoked Seizure Associated With Kratom Ingestion	Disclosure: Dr. Burke has nothing to disclose.
Child Neurology: Movement Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	030	Alice in Wonderland Syndrome: Case Series and Analysis	Disclosure: Dr. Fine has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	030	The importance of intra-operative assessment in VIM DBS for Tremor: Insights from 145 procedures	Disclosure: Dr. Mahajan has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	031	Cerebrovascular manifestations of herpes simplex virus infection of the central nervous system: a systematic review	Disclosure: Dr. Sellner has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	031	The Marburg Multiple Sclerosis - Cohort — Loss of MEDA under two standard treatment sequences	Disclosure: Dr. Jurs has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Vertebral and Basilar Artery Disease
Start Time	Pub.	Title	Presenter
11:30 AM	031	Thermoregulatory Dysfunction in a Patient with Locked-in Syndrome Due to Bilateral Ventral Pontine Infarction	Disclosure: Dr. Jordan has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	031	Multielectrode array analysis of human iPSC-motor neuron maturation following co-culture with iPSC- spinal cord astrocytes	Disclosure: Dr. Taga has nothing to disclose.
Epilepsy: General Medical Issues, PNES, and Other
Start Time	Pub.	Title	Presenter
11:30 AM	031	Medically Refractory Epilepsy Associated with Celiac Disease	Disclosure: Dr. Postelnik has nothing to disclose.
Child Neurology: Movement Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	031	Neuropsychological Assessment In Patients With Alternating Hemiplegia Of Childhood (AHC)	Disclosure: Dr. Fernandes has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	031	Risk Factors Causing Extended Hospitalizations due to Altered Arousal and Speech Dysfunction Following Deep Brain Stimulation for Essential Tremor	Disclosure: Dr. Anderson has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	032	Super Refractory Status Epilepticus Secondary to La Crosse Virus Encephalitis: A Case Report	Disclosure: Dr. Mohl has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	032	Immunosuppresion following alemtuzumab in relapsing-remitting multiple sclerosis patients previously treated with fingolimod	Disclosure: Dr. Cabrera Maqueda has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Vertebral and Basilar Artery Disease
Start Time	Pub.	Title	Presenter
11:30 AM	032	Outcome in Acute Basilar Artery Occlusion Based on Time and Severity at Presentation: A Retrospective Review	Disclosure: Dr. Suriya has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	032	Patient-Reported Outcomes Measures in Children with Spinal Muscular Atrophy	Disclosure: Dr. Risson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Novartis Pharma AG, Basel, Switzerland.
Epilepsy: General Medical Issues, PNES, and Other
Start Time	Pub.	Title	Presenter
11:30 AM	032	Profile and Outcome of Psychogenic Nonepileptic Seizures Patients undergoing Video-EEG Monitoring	Disclosure: Dr. Wolfe has nothing to disclose.
Child Neurology: Movement Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	032	Insights into Alternating Hemiplegia of Childhood from EEG Monitoring during an Episode, and Successful Prophylaxis with Levetiracetam	Disclosure: Dr. Mirzoev has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	032	Distinguishing tremor components in Essential Tremor: a digital spirography study	Disclosure: Dr. Osterholt has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	033	Unusual movement disorders and atypical MRI findings in patients with West Nile Encephalitis: A case series of two patients with evidence of clinical and imaging resolution with IVIG	Disclosure: Dr. Sheikh has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	033	PML Risk Perception in Patients Initiating Natalizumab for Multiple Sclerosis	Disclosure: Dr. Berkovich has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acorda, Avanir, Bayer, Biogen, Novartis, Questcor, Sanofi, and Teva. Dr. Berkovich has received research support from Acorda, Avanir, Bayer, Biogen, Novartis, Questcor, Sanofi, and Teva.
Cerebrovascular Disease and Interventional Neurology: Vertebral and Basilar Artery Disease
Start Time	Pub.	Title	Presenter
11:30 AM	033	Association of Functional Outcome in Basilar Artery Occlusion in Relation to Baseline Comorbidities: A Retrospective Review	Disclosure: Dr. Bzdyra has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	033	Co-existing riboflavin transporter deficiency (RTD) type 2 and muscle AMP deaminase deficiency in two long-term RTD survivors: report of a family	Disclosure: Dr. Zhang has nothing to disclose.
Epilepsy: General Medical Issues, PNES, and Other
Start Time	Pub.	Title	Presenter
11:30 AM	033	An Institutional Experience on Semiology of Psychogenic Nonepileptic Seizures	Disclosure: Dr. Fahimi has nothing to disclose.
Child Neurology: Movement Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	033	A Very Rare Cause of a Common Tremor	Disclosure: Dr. Kabbani has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	033	Cortical hyperexcitability in sialidosis type 1	Disclosure: Dr. Vial has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	034	Elsberg Syndrome, The Often Missed Other Cauda Equina	Disclosure: Dr. Yogendran has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	034	Temporal profile of lymphocytes following treatment with cladribine tablets in patients switching from lymphocyte depleting or sequestering disease modifying drugs (DMDs)	Disclosure: Dr. Hodgkinson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck, Sanofi Genzyme, Novartis.
Cerebrovascular Disease and Interventional Neurology: Vertebral and Basilar Artery Disease
Start Time	Pub.	Title	Presenter
11:30 AM	034	Interrater Agreement for Measurements of Vertebral Artery Origin Stenosis	Disclosure: Dr. Bell has nothing to disclose.
Motor Neuron Disease
Start Time	Pub.	Title	Presenter
11:30 AM	034	Effect of Radicava on Uric Acid Levels: Preliminary Results	Disclosure: Dr. Heiman-Patterson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Cytokinetics, Mitsubishi Tanabe, PTC Therapeutics.
Epilepsy: General Medical Issues, PNES, and Other
Start Time	Pub.	Title	Presenter
11:30 AM	034	Serum Levels of Inflammasome Complex Factors are Suppressed in Focal Epilepsy Patients	Disclosure: Dr. Yavuz has nothing to disclose.
Child Neurology: Movement Disorders
Start Time	Pub.	Title	Presenter
11:30 AM	034	KMT2B early childhood onset dystonia presenting as failure to thrive	Disclosure: Dr. Ng has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	034	Hyperkinetic Movement Disorders Associated With Immunosuppressant And Cefepime Use In Inpatients	Disclosure: Dr. Couto has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	035	A 59-year-old Immunocompetent Man with Rapid Onset of Truncal Ataxia: A Case of Acute Cerebellitis Secondary to Varicella Zoster Virus.	Disclosure: Dr. Cross has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	035	Predicting Natalizumab Discontinuation due to Breakthrough Disease in Multiple Sclerosis Patients	Disclosure: Dr. Conway has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Arena pharmaceuticals. Dr. Conway has received personal compensation in an editorial capacity for Neurotherapeutics. Dr. Conway has received research support from Novartis Pharmaceuticals.
Cerebrovascular Disease and Interventional Neurology: Vertebral and Basilar Artery Disease
Start Time	Pub.	Title	Presenter
11:30 AM	035	Comparison Between Medical Therapy And Endovascular Treatment Of Extracranial Atherosclerotic Vertebral Artery Disease: A Systematic Review	Disclosure: Dr. Daniel has nothing to disclose.
Neurophysiology in Neuromuscular Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	035	Hybrid Recording System of Electromyography and Ultrasound in Neuromuscular Disorder	Disclosure: Dr. Sekiguchi has nothing to disclose.
Child Neurology: Neuroinflammatory Disease
Start Time	Pub.	Title	Presenter
11:30 AM	035	Cortical Abnormalities and Cognitive Impairment in Pediatric MS Patients	Disclosure: Dr. De Meo has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	035	Effects of Concomitant Medication Use on Tardive Dyskinesia Outcomes in Long-Term Valbenazine Trials	Disclosure: Dr. Comella has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acorda Therapeutics, Allergan, Inc; Lundbeck Ltd.; Merz Pharmaceuticals;Acadia Pharmaceuticals; Ipsen Pharmaceuticals, Jazz Pharmaceuticals, Neurocrine Biosciences Inc., Revance Therapeutic, Sunovion., AEON Biopharma. She receives royalties from Cambridge, Wolters Kluwer. . Dr. Comella has received research support from Acorda, Revance, Merz, Eisai, Jazz Pharmacuetical.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	036	Oculomeningoencephalomyeloradiculitis: A case of fulminant varicella zoster infection in the setting of systemic lupus erythematosus	Disclosure: Dr. Perrone has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	036	Skin Warts during Fingolimod Treatment in Patients with Multiple Sclerosis	Disclosure: Dr. Yamout has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Bayer, Biogen, Genpharm, Genzyme, Merck-Serono, Novartis. Dr. Yamout has received research support from Bayer, Biogen, Merck-Serono, Novartis, Pfizer.
Cerebrovascular Disease and Interventional Neurology: Vertebral and Basilar Artery Disease
Start Time	Pub.	Title	Presenter
11:30 AM	036	Prevalence of Atherosclerotic Vertebrobasilar Disease in patients with Ischemic Stroke in an Argentinian cohort of patients	Disclosure: Dr. Bandeo has nothing to disclose.
Neurophysiology in Neuromuscular Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	036	Safety of Needle Electromyography in Critically Ill Intensive Care Unit (ICU) Patients	Disclosure: Dr. Nagarajan has nothing to disclose.
Epilepsy: General Medical Issues, PNES, and Other
Start Time	Pub.	Title	Presenter
11:30 AM	036	Spanish Epilepsy Education Available on the Web	Disclosure: Dr. Duron has received personal compensation for consulting serving on a scientific advisory board speaking or other activities with Epilepsy Foundation of Greater Los Angeles.
Child Neurology: Neuroinflammatory Disease
Start Time	Pub.	Title	Presenter
11:30 AM	036	Imaging analysis differentiates vascular versus inflammatory myelopathies in children	Disclosure: Dr. Garcia-Dominguez has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	036	RECLAIM-DCP: A Randomized, Double-Blind, Placebo-Controlled Study of Deutetrabenazine for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents	Disclosure: Dr. Claassen has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva Neuroscience, Lundbeck, Acadia, AbbVie. Dr. Claassen has received research support from NIH/NINDS, Michael J. Fox Foundation, Huntington Disease Society of America, Vaccinex, AbbVie, Auspex Pharmaceuticals.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	037	A Novel Case of Herpes Simplex Encephalitis Complicated by Cerebral Venous Thrombosis	Disclosure: Dr. Eibling has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with TrueLearn .
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	037	Limited Effects of Interferon ß-1a in an IgG-driven Model of Multiple Sclerosis Pathology	Disclosure: Dr. Bennett has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Viela Bio, Genentech, Alexion, Roche, Chugai, Frequency Therapeutics, Clene Neuroscience, and Reistone. Dr. Bennett has received royalty, license fees, or contractual rights payments from Pure Biologics. Dr. Bennett has received research support from Mallinckrodt, EMD Serono
Cerebrovascular Disease and Interventional Neurology: Vertebral and Basilar Artery Disease
Start Time	Pub.	Title	Presenter
11:30 AM	037	Second Generation Drug-Eluting Stents for Endovascular Treatment of Ostial Vertebral Artery Stenosis: A Single-Center Experience	Disclosure: Dr. Mendez Ruiz has nothing to disclose.
Child Neurology: Neuroinflammatory Disease
Start Time	Pub.	Title	Presenter
11:30 AM	037	Autoimmune encephalitis associated with N-type voltage-gated calcium channels in children: a case series	Disclosure: Dr. Kornitzer has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	037	Diagnosis and Treatment Experiences in a Real-World Sample of Tourette Syndrome and Tic Disorder Sufferers	Disclosure: Dr. Malaty has received research support from Abbvie, Auspex, Biogen, Biotie, Impax, Intrepid, Lundbeck, Nuvelution, Pfizer, and Revance.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	038	Neuroinvasive Spectrum of West Nile Virus.	Disclosure: Dr. Srinivas has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	038	Autoimmune Hemolytic Anemia after Treatment with Fingolimod: A Case Report	Disclosure: Dr. Husain has nothing to disclose.
Cerebrovascular Disease and Interventional Neurology: Vertebral and Basilar Artery Disease
Start Time	Pub.	Title	Presenter
11:30 AM	038	: Vertebral artery origin stenosis: systematic review of randomized clinical trials	Disclosure: Dr. Ezepue has nothing to disclose.
Neurophysiology in Neuromuscular Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	038	The Neurophysiology of Oxaliplatin Effects on Peripheral Nerve	Disclosure: Dr. Stecker has received royalty, license fees, or contractual rights payments from UPTODate.
Child Neurology: Neuroinflammatory Disease
Start Time	Pub.	Title	Presenter
11:30 AM	038	Autoimmune Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Following Herpes Simplex Encephalitis (HSE) in a pediatric patient	Disclosure: Dr. Handoko has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	038	Self-Reported Substance Use in a Real-World Sample of Subjects with Tourette Syndrome and Other Tic Disorder.	Disclosure: Dr. Deeb has received research support from Tools4Patients.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	039	Post-operative HSV-2 Encephalitis Following Temporal Lobe Resection for Glioblastoma Multiforme	Disclosure: Dr. Mingbunjerdsuk has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	039	Longitudinal analysis of Peripheral Blood Mononuclear Cells in Lymphopenic and Non-lymphopenic Relapsing-Remitting Multiple Sclerosis (RRMS) patients treated with Dimethyl Fumarate	Disclosure: Dr. Nakhaei-Nejad has nothing to disclose.
Stroke Genetics and Epidemiology
Start Time	Pub.	Title	Presenter
11:30 AM	039	Concerning Temporal Trends in Transient Ischemic Attack Hospitalization	Disclosure: Dr. Sahawneh has nothing to disclose.
Neurophysiology in Neuromuscular Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	039	Increased Incidence of Martin Gruber Anastomosis in Individuals with Ulnar Neuropathy	Disclosure: Dr. Gandhy has nothing to disclose.
Child Neurology: Neuroinflammatory Disease
Start Time	Pub.	Title	Presenter
11:30 AM	039	Unilateral Primary CNS Vasculitis in a Child Associated with Increased ICP and Treated with Maximal Medical Therapy and Decompressive Hemicraniectomy	Disclosure: Dr. Wang has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	039	Physical activity, sleep and tic severity in children	Disclosure: Dr. Pringsheim has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	040	Acute Myositis in Three Adult Men with Rapid Resolution	Disclosure: Dr. Danielson has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	040	Stability of JC Virus Index over Time – a Five Year Retrospective Study.	Disclosure: Dr. Gaughan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Roche, Novartis, Abbvie, Biogen. Dr. Gaughan has received research support from Roche via Newman Fellowship, University College Dublin.
Stroke Genetics and Epidemiology
Start Time	Pub.	Title	Presenter
11:30 AM	040	Healthcare Utilization Prior to Fatal Stroke Admission: Nationally Representative Data	Disclosure: Dr. Levy has nothing to disclose.
Neurophysiology in Neuromuscular Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	040	The Sensitivites of Median Mixed Palmar Distal Latencies in the Diagnosis of Carpal Tunnel Syndrome (Onset, Peak, Either Onset or Peak, or Onset and Peak)	Disclosure: Dr. Sader has nothing to disclose.
Child Neurology: Neuroinflammatory Disease
Start Time	Pub.	Title	Presenter
11:30 AM	040	Disability Scores After Idiopathic Pediatric Transverse Myelitis are Associated with Clinical Features at Onset of Illness	Disclosure: Dr. Cole has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	040	The Impact of Tourette Syndrome and Tic Disorders on Education, Occupational, and Personal Life	Disclosure: Dr. Malaty has received research support from Abbvie, Auspex, Biogen, Biotie, Impax, Intrepid, Lundbeck, Nuvelution, Pfizer, and Revance.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	041	West Nile Radiculomyelitis	Disclosure: Dr. Vinokur has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	041	Characterization of the Peripheral Blood Transcriptome in Alemtuzumab-Treated Relapsing-Remitting Multiple Sclerosis Patients From the CARE-MS I and II Studies	Disclosure: Dr. Zhang has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sanofi.
Stroke Genetics and Epidemiology
Start Time	Pub.	Title	Presenter
11:30 AM	041	A Comparative Case Series of Haitian and non-Haitian Acute Stroke Patients at a Single Center in Miami, Florida	Disclosure: Dr. Ashourian has nothing to disclose.
Neurophysiology in Neuromuscular Disorders II
Start Time	Pub.	Title	Presenter
11:30 AM	041	The effect of botulinum toxin injections on EMG	Disclosure: Dr. Petrizzo has nothing to disclose.
Child Neurology: Neuroinflammatory Disease
Start Time	Pub.	Title	Presenter
11:30 AM	041	Limbic Encephalitis as Presentation of Hodgkin Lymphoma in a Pediatric Patient: The Ophelia Syndrome	Disclosure: Dr. Tuttrup has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	041	Assessing the social determinants of health in Tourette Syndrome	Disclosure: Dr. Dy has nothing to disclose.
Neurovirology
Start Time	Pub.	Title	Presenter
11:30 AM	042	Measles encephalitis without CSF pleocytosis and typical rash: a case report	Disclosure: Dr. Ahn has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	042	The Effect of Ocrelizumab Therapy on Immunoglobulin Levels in Patients with Multiple Sclerosis	Disclosure: Dr. Tran has nothing to disclose.
Stroke Genetics and Epidemiology
Start Time	Pub.	Title	Presenter
11:30 AM	042	Stroke in Himalayan Region of Nepal: Knowledge and Awareness of Early Management	Disclosure: Dr. Ojha has nothing to disclose.
Child Neurology: Neuroinflammatory Disease
Start Time	Pub.	Title	Presenter
11:30 AM	042	Prospective characterization of children positive for anti-MOG antibodies meeting Multiple Sclerosis diagnostic criteria	Disclosure: Dr. Fadda has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sanofi Genzyme.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	042	Development of an EMG Based Tic Detector	Disclosure: Dr. Deeb has received research support from Tools4Patients.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	043	Potassium Bromide: The First Successful Treatment of Epilepsy	Disclosure: Dr. Peng has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	043	VERISMO: A Post-Marketing Safety Study to Determine the Incidence of All Malignancies and Breast Cancer in Patients With Multiple Sclerosis Treated With Ocrelizumab	Disclosure: Dr. Wormser has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with F. Hoffman-La Roche Ltd. Dr. Wormser has received compensation for serving on the Board of Directors of F. Hoffman-La Roche Ltd. Dr. Wormser has received research support from F. Hoffman-La Roche Ltd.
Stroke Genetics and Epidemiology
Start Time	Pub.	Title	Presenter
11:30 AM	043	Acute Stroke Management: A Plight of Nepal	Disclosure: Dr. Chandra has nothing to disclose.
Child Neurology: Leukodystrophies
Start Time	Pub.	Title	Presenter
11:30 AM	043	Natural History of Neurological and Neuroimaging Progression in Childhood Cerebral X-Linked Adrenoleukodystrophy (CCALD).	Disclosure: Dr. Almuqbil has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	043	Prescriptions for Alpha Agonists and Antipsychotics in Children and Youth with Tic Disorders: A National Pharmacoepidemiologic Study	Disclosure: Dr. Cothros has nothing to disclose.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	044	John Yerbury Dent and Apomorphine: an unfinished history	Disclosure: Dr. Auffret has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	044	ADA Genetic Variants Influence Central Inflammation and Clinical Characteristics in MS: Implications for Cladribine Treatment	Disclosure: Dr. Bassi has nothing to disclose.
Stroke Genetics and Epidemiology
Start Time	Pub.	Title	Presenter
11:30 AM	044	Hospital-based Stroke Register Studies and Clinical Features and Outcomes of Stroke Patients in China and other Asian Countries: A Systematic Review	Disclosure: Dr. Ye has nothing to disclose.
Child Neurology: Leukodystrophies
Start Time	Pub.	Title	Presenter
11:30 AM	044	Developmental outcomes of Aicardi Goutières Syndrome	Disclosure: Dr. Adang has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	044	Longitudinal follow-up of dual-lead thalamic deep brain stimulation for patients with treatment refractory multiple sclerosis tremor	Disclosure: Dr. Patel has nothing to disclose.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	045	Women in History: Neuromuscular Medicine	Disclosure: Dr. Aziz-Donnelly has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	045	Dissection of the Distinct Susceptibility of Hematopoietic Precursors and Immune Cells to Cladribine	Disclosure: Dr. Carlini has nothing to disclose.
Stroke Genetics and Epidemiology
Start Time	Pub.	Title	Presenter
11:30 AM	045	Effect of Documentation Patterns on Prevalence of Comorbid Conditions in Ischemic Stroke	Disclosure: Dr. Jillella has nothing to disclose.
Child Neurology: Leukodystrophies
Start Time	Pub.	Title	Presenter
11:30 AM	045	Autoimmune hepatitis in Aicardi-Goutières Syndrome	Disclosure: Dr. Cross has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	045	Outcomes with VIM deep brain stimulation in dystonic tremor versus essential tremor	Disclosure: Dr. Tsuboi has nothing to disclose.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	046	Marie-Foix Syndrome: A Classical Crossed Pontine Syndrome?	Disclosure: Dr. Delgado-Garcia has received research support from Carlos Slim Foundation.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	046	Updated safety analysis of cladribine tablets in the treatment of patients with multiple sclerosis	Disclosure: Dr. Cook has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck, Bayer HealthCare, Sanofi-Aventis, Neurology Reviews, Biogen Idec, Teva Pharmaceuticals, Bayer HealthCare, Merck, Actinobac Biomed, Teva Pharmaceuticals, Biogen Idec and Actinobac Biomed, Inc. Dr. Cook has received research support from Bayer HealthCare.
Stroke Genetics and Epidemiology
Start Time	Pub.	Title	Presenter
11:30 AM	046	Genome-wide DNA methylation profiling in peripheral blood from different TOAST-subtypes stroke patients.	Disclosure: Dr. Marta-Enguita has nothing to disclose.
Child Neurology: Leukodystrophies
Start Time	Pub.	Title	Presenter
11:30 AM	046	Cross-analysis of Interferon Signature in a cohort of Aicardi-Goutières Syndrome subjects	Disclosure: Dr. Gavazzi has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	046	Smartphone Accelometry in Diagnosing Orthostatic Tremor	Disclosure: Dr. Calvo has nothing to disclose.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	047	Conceptualizing Consciousness as Arousal+Awareness – Historical Parallels from Indian Philosophy	Disclosure: Dr. Venkatraman has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	047	Efficacy and Safety of Teriflunomide in Patients of Differing Ages: Analysis of Pooled Clinical Trials	Disclosure: Dr. Oh has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen Idec, EMD Serono, Genzyme, Novartis, Roche. Dr. Oh has received research support from Biogen Idec, Genzyme, MS Society of Canada, Teva.
Stroke Genetics and Epidemiology
Start Time	Pub.	Title	Presenter
11:30 AM	047	Serious Misdiagnosis-Related Harms Due to Missed Vascular Events in the United States—Incidence, Settings, and Causes	Disclosure: Dr. Saber Tehrani has nothing to disclose.
Child Neurology: Leukodystrophies
Start Time	Pub.	Title	Presenter
11:30 AM	047	Consensus Guidelines: MRI Surveillance of Children with Presymptomatic Adrenoleukodystrophy	Disclosure: Dr. Turk has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	047	Psychiatric Comorbidities in United States Military Veterans with Movement Disorders in Tampa, Florida	Disclosure: Dr. Gandhy has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Genentech, Biogen Idec, and Sanofi-Aventis Pharmaceuticals, Inc. Dr. Gandhy holds stock and/or stock options in Ultragenyx, Sangamo, Codexis, Editas, Crispr, Intellia, and PTC Therapeutics.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	048	Babinski’s sign from the evolutional point of view "Why would you think that the big toe is related to your brain?"	Disclosure: Dr. Elsaid has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	048	Effects of Fingolimod on Cytokine and Chemokine Levels in Patients with Multiple Sclerosis	Disclosure: Dr. Kurtuncu has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck, Novartis, Teva, Genzyme, Bayer, Roche.
Heart Brain Connections
Start Time	Pub.	Title	Presenter
11:30 AM	048	Prevalence and Prognosis of Atrial Fibrillation Among Hospitalized Ischemic Stroke Patients with Comobid Seizures in the United States	Disclosure: Dr. Lekoubou Looti has nothing to disclose.
Child Neurology: Leukodystrophies
Start Time	Pub.	Title	Presenter
11:30 AM	048	Metachromatic Leukodystrophy: An Approach to Treatment	Disclosure: Dr. Krarup has received research support from Integra Life Sciences Shire HGT.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	048	TANGO2 Mutation: A Novel Cause of Movement Disorders	Disclosure: Dr. Burns has nothing to disclose.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	049	The History of Neurological Serendipities	Disclosure: Dr. Nisar has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	049	Effects of Ocrelizumab on Immune Parameters in a Cohort of MS Patients	Disclosure: Dr. Hu has nothing to disclose.
Heart Brain Connections
Start Time	Pub.	Title	Presenter
11:30 AM	049	Factors associated with atrial fibrillation detection on longterm cardiac monitoring in Stroke	Disclosure: Dr. Khalife has nothing to disclose.
Child Neurology: Leukodystrophies
Start Time	Pub.	Title	Presenter
11:30 AM	049	Expanded Phenotype of GFPT1-related Disorder is a Mimicker of Mitochondrial Leukoencephalopathy	Disclosure: Dr. Helman has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	049	Hereditary Spastic Paraplegia: The Relationships of Patient Perceived Functional Impact and Objective Quantified Multi-Dimensional Gait Analysis	Disclosure: Dr. Srinivasan has nothing to disclose.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	050	Ophelia’s syndrome revisited.	Disclosure: Dr. Soto-Rincon has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	050	Intrathecal MSC-NP Treatment in Patients with Progressive Multiple Sclerosis is Associated with Modulation of Cerebrospinal Fluid Biomarkers	Disclosure: Dr. Zanker has nothing to disclose.
Heart Brain Connections
Start Time	Pub.	Title	Presenter
11:30 AM	050	N-Terminal Probrain Natriuretic Peptide as a marker for diagnosis of Cardioembolic Stroke	Disclosure: Dr. Shah has nothing to disclose.
Child Neurology: Leukodystrophies
Start Time	Pub.	Title	Presenter
11:30 AM	050	Language Skills in Children with Alexander Disease	Disclosure: Dr. Levin has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	050	Autonomic Testing Profiles in Scans Without Evidence of Dopaminergic Deficit (SWEDD)	Disclosure: Dr. Jackson has nothing to disclose.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	051	Wenceslao López Albo: the unsuspected influence of Cajal and Charcot on Monterrey, México	Disclosure: Dr. Castillo-Torres has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	051	Immunological phenotyping identifies a subgroup of MS patients experiencing a pro-inflammatory immune cell activation upon therapeutic B cell removal	Disclosure: Dr. Häusser-Kinzel has nothing to disclose.
Heart Brain Connections
Start Time	Pub.	Title	Presenter
11:30 AM	051	Recurrent Ischemic Stroke secondary to Left Ventricular Non-compaction	Disclosure: Dr. Sivakumar has nothing to disclose.
Child Neurology: Leukodystrophies
Start Time	Pub.	Title	Presenter
11:30 AM	051	The Pediatric Evaluation of Disability Inventory Computer Adaptive Test Captures Impairments in Alexander Disease	Disclosure: Dr. Cooper has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	051	Novel Mutation of NUS1 Gene Presenting With Developmental and Epileptic Encephalopathy and Movement Disorders	Disclosure: Dr. Prakash has nothing to disclose.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	052	Headaches in Ulysses Grant	Disclosure: Dr. Sengupta has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	052	Turning mechanistic immunomodulatory insights into personalized treatment strategies for multiple sclerosis	Disclosure: Dr. Ntranos has nothing to disclose.
Heart Brain Connections
Start Time	Pub.	Title	Presenter
11:30 AM	052	Advanced Cardiac Imaging In Patients With Ischemic Stroke. When To Scan?	Disclosure: Dr. Orabi has nothing to disclose.
Child Neurology: Leukodystrophies
Start Time	Pub.	Title	Presenter
11:30 AM	052	Utilization of Wearable Technology to Characterize the Natural History of Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation	Disclosure: Dr. Smith has nothing to disclose.
Other Hyperkinetic Movement Disorders and Tremor
Start Time	Pub.	Title	Presenter
11:30 AM	052	Hemi Masticatory Spasm: Series of 8 Cases	Disclosure: Dr. Madathiparambil has nothing to disclose.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	053	Parallels to the Modern Understanding of Speech Production in Indian Philosophical History	Disclosure: Dr. Venkatraman has nothing to disclose.
MS Therapeutics: MOA and Safety
Start Time	Pub.	Title	Presenter
11:30 AM	053	Delayed-release Dimethyl Fumarate Treatment Shifts the Immune Repertoire in Patients With Relapsing-Remitting Multiple Sclerosis: Results of PROCLAIM, an Open-label Phase 3 Study	Disclosure: Dr. Robertson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, Celgene, Sanofi-Genzyme, Genentech, EMD Serono, Novartis, Teva Neuroscience, Acorda, EMD Serono, Mallinckrodt, and Novartis. Dr. Robertson has received research support from Actelion, Biogen, Genentech, Mallinckrodt, MedDay Pharmaceuticals, MedImmune, Novartis, Sanofi-Genzyme, Sun Pharma, PCORI, and TG Therapeutics.
Heart Brain Connections
Start Time	Pub.	Title	Presenter
11:30 AM	053	Neurologic Complications during Short-term Cardiac Support with Impella Devices	Disclosure: Dr. Hassett has nothing to disclose.
Child Neurology: Leukodystrophies
Start Time	Pub.	Title	Presenter
11:30 AM	053	The Children’s Hospital of Philadelphia Pediatric Dysphagia Instrument (CHOP PDI): a Novel Tool for Swallow Dysfunction	Disclosure: Dr. Minkoff has nothing to disclose.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	054	Gender Disparity Between Neurologists in Brazil: Is It Really Decreasing?	Disclosure: Dr. Dias Veloso has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	054	Clinical and Radiological Correlates of Multiple Sclerosis in patients of Middle Eastern and North African ancestry residing in Ontario, Canada.	Disclosure: Dr. Seyman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen-Idec. Dr. Seyman has received research support from Novartis.
Heart Brain Connections
Start Time	Pub.	Title	Presenter
11:30 AM	054	Rate of ischemic stroke and intracranial hemorrhage following left ventricular assist device placement: a systematic review	Disclosure: Dr. Alhaidar has nothing to disclose.
Child Neurology: Leukodystrophies
Start Time	Pub.	Title	Presenter
11:30 AM	054	A Comprehensive and Dynamic Approach for Genetic Testing for Patient with Leukodystrophy Demonstrates a Genetic Etiology in 33% of Cases	Disclosure: Dr. Zou has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with GeneDx.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	055	An 8,000-year History of Use and Abuse of Opium and Opioids: How That Matters For A Successful Control Of The Epidemic ?	Disclosure: Dr. Bandyopadhyay has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	055	The Frequency of Longitudinally Extensive Transverse Myelitis in Multiple Sclerosis in the Era of Glial Biomarkers; A Population-Based Study	Disclosure: Dr. Asnafi has nothing to disclose.
Heart Brain Connections
Start Time	Pub.	Title	Presenter
11:30 AM	055	Therapeutic Anticoagulation after Ischemic Stroke in Patients with LVADs does not cause Hemorrhagic Conversion: A Single Center Retrospective Study	Disclosure: Dr. Ruta has nothing to disclose.
Child Neurology: Leukodystrophies
Start Time	Pub.	Title	Presenter
11:30 AM	055	Novel Classifications of Alexander Disease Based on MRI Phenotypes	Disclosure: Dr. Waldman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with UpToDate, Optum Inc.. Dr. Waldman holds stock and/or stock options in Spark, Thermo Fisher, Pfizer. Dr. Waldman has received research support from Ionis Pharmaceuticals.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	056	A History of Dihydroergotamine in Migraine	Disclosure: Dr. Ray has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Impel NeuroPharma.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	056	Integrative analysis of risk burden, microbiome and metabolome in people at risk for multiple sclerosis	Disclosure: Dr. Xia has nothing to disclose.
Heart Brain Connections
Start Time	Pub.	Title	Presenter
11:30 AM	056	Simultaneous cardio-cerebral infarction: A rare phenomenon	Disclosure: Dr. Goyal has nothing to disclose.
Child Neurology: Leukodystrophies
Start Time	Pub.	Title	Presenter
11:30 AM	056	Clinical Outcome Assessments in TUBB4A-associated Leukoencephalopathies	Disclosure: Dr. Vanderver holds stock and/or stock options in Aetna. Dr. Vanderver has received research support from Illumina, Shire, Gilead, Eli Lilly.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	057	Torres Homem and the Book “Lessons about Nervous System Diseases” of 1878	Disclosure: Dr. Correa Neto has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	057	Variation in Employment Status among People with MS in the United States, United Kingdom and Germany	Disclosure: Dr. Salter has received personal compensation in an editorial capacity as a statistical consultant for Circulation: Cardiovascular Imaging.
Heart Brain Connections
Start Time	Pub.	Title	Presenter
11:30 AM	057	A Retrospective Analysis of Anticoagulation Reinstitution in Patients with Left Ventricular Assist Device who Developed Intracerebral Hemorrhage at Mayo Clinic Arizona	Disclosure: Dr. Dawit has nothing to disclose.
Child Neurology: Leukodystrophies
Start Time	Pub.	Title	Presenter
11:30 AM	057	Diagnostic tips from a case series of patients with Late Onset Tay Sachs disease	Disclosure: Dr. Riboldi has nothing to disclose.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	058	Sir Roger Bannister: The Fastest and Famed Neurologist	Disclosure: Dr. Mayberry has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	058	Increased Risk of Comorbidities in Patients Before and After Multiple Sclerosis Diagnosis and Initiation of Treatment: A Study Using the US Department of Defense Database	Disclosure: Dr. Persson has received research support from Celgene Corporation.
Heart Brain Connections
Start Time	Pub.	Title	Presenter
11:30 AM	058	Comparison of Point of Care Ultrasound to Standard Transthoracic Echocardiography for Acute Stroke and TIA	Disclosure: Dr. aijb has nothing to disclose.
Child Neurology: Metabolic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	058	AGIL-AADC Gene Therapy Results in Sustained Improvements in Motor and Developmental Milestones Over 5 Years in Children With AADC Deficiency	Disclosure: Dr. Chien has nothing to disclose.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	059	Charcot's 1886 Preface to Sœur Jeanne des Anges : Autobiographie d'une hysterique possédée: An English Rendition	Disclosure: Dr. Delgado-García has received personal compensation in an editorial capacity for Neurology Resident and Fellow section. Dr. Delgado-García has received research support from Fundacion Carlos Slim.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	059	Prevalence of Vascular Co-morbidities in patients with Multiple Sclerosis in a Racially Diverse and Low Socioeconomic Status Population	Disclosure: Dr. Hellerslia has nothing to disclose.
Heart Brain Connections
Start Time	Pub.	Title	Presenter
11:30 AM	059	Neurological outcomes of patients with mycotic aneurysms in infective endocarditis	Disclosure: Dr. Shi has nothing to disclose.
Child Neurology: Metabolic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	059	Patients with Inherited Metabolic Disorders (IMD) transplanted with MGTA-456, a CD34+ Expanded Cell Therapy Product, Show Rapid Engraftment in Preliminary Phase 2 Trial Results	Disclosure: Dr. Orchard has received research support from Magenta Therapeutics.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	060	Hypogonadism, alopecia and neurological manifestations: evolving syndromes from an old association.	Disclosure: Dr. Abusrair has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	060	Untreated Patients with Multiple Sclerosis: Prevalence and Characteristics in Denmark and in the United States	Disclosure: Dr. Nørgaard has nothing to disclose.
Heart Brain Connections
Start Time	Pub.	Title	Presenter
11:30 AM	060	Outcome of Thrombectomy in Stroke Due to Infective Endocarditis: A Case Series	Disclosure: Dr. Sader has nothing to disclose.
Child Neurology: Metabolic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	060	Exploring mTOR Inhibition as Treatment for Mitochondrial Disease	Disclosure: Dr. Sage has nothing to disclose.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	061	S. Weir Mitchell, Successes and Failures of the Father of American Neurology	Disclosure: Dr. Kalikstein has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	061	Diet during adolescence and association with Multiple Sclerosis in Colombian patients	Disclosure: Dr. Toro has received personal compensation in an editorial capacity for New England Journal of Medicine Journal Watch Neurology and Multiple Sclerosis and Related Disorders.
Heart Brain Connections
Start Time	Pub.	Title	Presenter
11:30 AM	061	Utility Of Retrieved Thromboembolism Tissue Culture In A Patient With Suspected Infective Endocarditis	Disclosure: Dr. Patel has nothing to disclose.
Child Neurology: Metabolic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	061	Exploring Triheptanoin as Treatment for Short Chain Enoyl CoA Hydratase Deficiency	Disclosure: Dr. Engelstad has nothing to disclose.
History of Neurology
Start Time	Pub.	Title	Presenter
11:30 AM	062	Neurological Illness on the Supreme Court	Disclosure: Dr. Farbman has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Dr. Farbman has received honoraria for advisory board participation from Teva Pharmaceuticals and UCB.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	062	Multiple Sclerosis Prevalence Rates Within a Healthcare Delivery System in Northern California: A Retrospective, Electronic Health Records-Based Study From 2010 to 2016	Disclosure: Dr. Romanelli has received research support from Janssen, Regeneron, and Sanofi.
Heart Brain Connections
Start Time	Pub.	Title	Presenter
11:30 AM	062	Prior Antithrombotic Therapy is Associated with Cerebral Microbleeds in Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease	Disclosure: Dr. Cheng has nothing to disclose.
Child Neurology: Metabolic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	062	Mitochondrial Dysfunction: Consider SPATA5 mutations	Disclosure: Dr. Khurana has nothing to disclose.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	063	Reimbursement Does Not Cover Inpatient Costs for tPA-Managed Patients As tPA Cost Has Continued to Rise	Disclosure: Dr. Sila has received personal compensation for consulting serving on a scientific advisory board speaking or other activities with Bristol Myers Squibb Coherex.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	063	Dietary Intake and the Effect on Disease Progression in People with Multiple Sclerosis	Disclosure: Dr. Meier-Gerdingh has nothing to disclose.
Heart Brain Connections
Start Time	Pub.	Title	Presenter
11:30 AM	063	Trends of patent foramen ovale (PFO) closure from 2008 to 2014 at National level: US experience	Disclosure: Dr. Khatri has nothing to disclose.
Child Neurology: Metabolic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	063	Can pathology help in functional interpretation of genetic variants – A case report of Novel variants in NARS2 gene with mitochondrial dysfunction presenting as early infantile epileptic encephalopathy with cardiac and skeletal muscle involvement	Disclosure: Dr. Heredia has nothing to disclose.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	064	Implementation of an electronic medical record-enhanced dashboard to optimize pre-rounding for residents on the Stroke Neurology service	Disclosure: Dr. O'Connor has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	064	Multiple Sclerosis (MS) and Neuromyelitis optica (NMO): Admission trends, In-hospital Events, Outcomes, Treatment and Regional Differences In Distribution: A study of the National Inpatient Sample 2006-2014	Disclosure: Dr. Afzal has nothing to disclose.
Heart Brain Connections
Start Time	Pub.	Title	Presenter
11:30 AM	064	Identifying Patients with Cryptogenic Stroke Eligible for PFO Closure	Disclosure: Dr. Al Banna has nothing to disclose.
Child Neurology: Metabolic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	064	Aberrant Mitophagy In The Pediatric Neurodegenerative Syndrome TBCKE	Disclosure: Dr. Tintos-Hernandez has nothing to disclose.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	065	Collaborative Care in Stroke Centers: Role of Neurologists in Implanting Loop Recorders for Detection of Atrial Fibrillation	Disclosure: Dr. Herial has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with medtronic.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	065	The Economic Impact of Multiple Sclerosis: A Preliminary Look at the North American Registry for Care and Research in Multiple Sclerosis (NARCRMS) (On behalf of the NARCRMS Health Economics Outcomes Research [HEOR] Advisory Group)	Disclosure: Dr. Livingston has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with EMD Serono, Biogen.
Heart Brain Connections
Start Time	Pub.	Title	Presenter
11:30 AM	065	Does Risk of Paradoxical Embolism (ROPE) score correlate with PFO closure criteria?	Disclosure: Dr. Salari has nothing to disclose.
Child Neurology: Metabolic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	065	Mitochondrial Encephalomyopathy, Lactic acidosis, And Stroke-like episodes(MELAS) manifesting with Intermittent Cortical Blindness secondary to Occipital Lobe Seizures	Disclosure: Dr. Ahmed has nothing to disclose.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	066	Transition Preparedness: a Pilot Study in Texas Children’s Hospital Muscular Dystrophy Care Clinic	Disclosure: Dr. Jackson has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	066	A Modified Mediterranean Dietary Intervention for Multiple Sclerosis: Results of a Pilot Study	Disclosure: Dr. Katz Sand has nothing to disclose.
Systemic Disease and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	066	The Impact of Chronic Kidney Disease Stage on Intracranial Vascular Resistance	Disclosure: Dr. Ghoshal has nothing to disclose.
Child Neurology: Metabolic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	066	Late-onset multiple acyl-CoA dehydrogenase deficiency with a complex genetic finding	Disclosure: Dr. Durães has nothing to disclose.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	067	Epilepsy: Transition from Pediatric to Adult Care. Recommendations of the Ontario Epilepsy Implementation Task Force	Disclosure: Dr. Andrade has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Stoke, Eisai and UCB.. Dr. Andrade has received royalty, license fees, or contractual rights payments from UpToDate.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	067	The North American Registry for Care and Research in Multiple Sclerosis (NARCRMS) (On behalf of the NARCRMS Site PIs)	Disclosure: Dr. Rammohan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Genzyme, Biogen, EMD Serono, Novartis, TG Therapeutics. Dr. Rammohan has received research support from Genentech, Biogen, EMD Serono, Novartis, Department of Defense.
Systemic Disease and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	067	Impact of renal failure on acute stroke	Disclosure: Dr. Appiani has nothing to disclose.
Child Neurology: Metabolic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	067	Undiagnosed Late-onset Ornithine transcarbamylase (OTC) Deficiency Presenting With Psychiatric Symptoms	Disclosure: Dr. Muzammil has nothing to disclose.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	068	Implementing Cognitive Behavior Screening in a Hispanic Cohort with Amyotrophic Lateral Sclerosis	Disclosure: Dr. Trikamji has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	068	Food Allergies Are Associated With Increased Disease Activity In Multiple Sclerosis	Disclosure: Dr. Fakih has nothing to disclose.
Systemic Disease and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	068	Stroke and Retinal Microvascular Abnormalities	Disclosure: Dr. Veasquez Carretero has nothing to disclose.
Child Neurology: Metabolic Disease
Start Time	Pub.	Title	Presenter
11:30 AM	068	Expanded newborn screening (NBS) leads to early diagnosis and treatment in children with Cobalamin C disease (CblC) and aids in identifying and treating presymptomatic affected family members	Disclosure: Dr. Herman has nothing to disclose.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	069	The AAN Live Well, Lead Well Program: Promoting Wellness through Leadership	Disclosure: Dr. Schwarz has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with EBSCO for review of Dynamed neurology submissions.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	069	The Impact of Social Capital on Patients with Multiple Sclerosis	Disclosure: Dr. Reyes has received research support from SR has received an ECTRIMS clinical training fellowship in 2018.
Systemic Disease and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	069	The Black Sheep of Stroke Etiologies: Visual Abnormalities and Cerebral Infarction in Association with Lambl’s Excrescences	Disclosure: Dr. Etter has nothing to disclose.
Child Neurology: Epilepsy I
Start Time	Pub.	Title	Presenter
11:30 AM	069	Epilepsy in Alternating Hemiplegia of Childhood: Characteristics, Neuroimaging, and Response to Therapy	Disclosure: Dr. Uchitel has nothing to disclose.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	070	A retrospective descriptive study to evaluate physician education on driving practices of patients who develop a neurological condition	Disclosure: Dr. Elliott has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	070	The Natural History of Primary Progressive Multiple Sclerosis in Buenos Aires, Argentina	Disclosure: Dr. Bensi has nothing to disclose.
Systemic Disease and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	070	Exploring the Relationship Between Chronic Obstructive Pulmonary Disease and Posterior Reversible Encephalopathy Syndrome—a possibly under-recognized cause of an uncommon syndrome	Disclosure: Dr. Amadife has nothing to disclose.
Child Neurology: Epilepsy I
Start Time	Pub.	Title	Presenter
11:30 AM	070	Loss of Function Variants in the CSTB Gene Cause Microcephaly, Developmental Delay, Hyperkinetic Movements, and Early Onset Epilepsy	Disclosure: Dr. Rogers has nothing to disclose.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	071	Documentation of Code Status in Hospitalized Patients: A Pilot Quality Improvement Project	Disclosure: Dr. Grewal has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	071	National estimate of incidence and predictors of 30-day readmission associated with multiple sclerosis using nationwide readmission database	Disclosure: Dr. Kumar has nothing to disclose.
Systemic Disease and Stroke
Start Time	Pub.	Title	Presenter
11:30 AM	071	Predictors of favorable response to the placement of the ventriculoperitoneal shunt in patients with idiopathic normal pressure hydrocephalus	Disclosure: Dr. Ricciardi has nothing to disclose.
Child Neurology: Epilepsy I
Start Time	Pub.	Title	Presenter
11:30 AM	071	Episodic status epilepticus with hemiplegia and involuntary movements associated with novel ATP1A2 mutation	Disclosure: Dr. Calame has nothing to disclose.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	072	Implementation of Standard Note Templates Captures True Level of Service (LOS) Coding	Disclosure: Dr. Shah has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	072	Lack of Low-Frequency Complete-Penetrance Coding Variants Responsible from Familial Multiple Sclerosis	Disclosure: Dr. Siva has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Merck, Novarti Pharmaceuticals, Teva, Sanofi Genzyme, Bayer, and Roche.
Child Neurology: Epilepsy I
Start Time	Pub.	Title	Presenter
11:30 AM	072	Behavioral alterations associated with the use of levetiracetam in pediatric patients with epilepsy	Disclosure: Dr. Manterola has nothing to disclose.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	073	Does CMS GMLOS In the Neurological ICU Represent Reality in Academic Medical Centers?	Disclosure: Dr. Hajighasemi-Ossareh has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	073	Oxysterols and Apolipoproteins in Multiple Sclerosis: A 5-year Follow-up Study	Disclosure: Dr. Ramanathan has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with EMD Serono, Biogen Idec, Pfizer Inc, the National Multiple Sclerosis Society, the Department of Defense, Jog for the Jake Foundation, the National Institutes of Health and National Science Foundation. Dr. Ramanathan has received personal compensation in an editorial capacity for Editor from the American Association of Pharmaceutical Scientists. Dr. Ramanathan has received research support from EMD Serono, Biogen Idec, Pfizer Inc, the National Multiple Sclerosis Society, the Department of Defense, Jog for the Jake Foundation, the National Institutes of Health and National Science Foundation.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	074	The Handoff Experience	Disclosure: Dr. Streicher has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	074	Generalizability of the Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS-PATHS) Data: Experience from a Single Site	Disclosure: Dr. Macaron has received research support from Biogen.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	075	Improving Hospital Discharge Time: An In-depth Analysis	Disclosure: Dr. Yuan has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	075	Late Onset Multiple Sclerosis: Clinical and Radiographic Characteristics	Disclosure: Dr. Thakolwiboon has nothing to disclose.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	076	Comparing Patient Perceptions on Multiple Sclerosis Management and Care – A Sub-analysis of Geographic Differences	Disclosure: Dr. Williams has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen, Teva Neuroscience, Bayer, Questcor Pharmaceuticals, EMD Serono, Merck KGaA, Pfizer, Novartis, Acorda, and Genzyme.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	076	Sociodemographic Factors Associated with Clinical Outcomes in CNS Inflammatory and Infectious Diseases: A Retrospective Cohort Study	Disclosure: Dr. Jia has nothing to disclose.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	077	RESIDENT DOCUMENTATION PRACTICES AND NEUROHOSPITALIST GROUP REVENUE	Disclosure: Dr. Pope has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	077	Driving Continuous Improvement of MS Care Quality –Year One Experience and Findings from the Multiple Sclerosis Continuous Quality Improvement (MS-CQI) Research Collaborative	Disclosure: Dr. Oliver has received research support from Biogen.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	078	Effects of Guideline on Prevalence of Cerebral Sinus Venous Thrombosis (CSVT) before and after 2011: Call to Action	Disclosure: Dr. Patel has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	078	Cognitive and clinical predictors of employment status among patients with Multiple Sclerosis in Argentina	Disclosure: Dr. Vanotti has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	079	Burnout among practicing neurologists in Massachusetts	Disclosure: Dr. Wu has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	079	Worsening of MS Associated With Relapse Contributes to Disability Over the First 15 years	Disclosure: Dr. Diehl has nothing to disclose.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	080	Impact of Transthoracic Echocardiogram on Length of Stay and Hospital Charges in Ischemic Stroke and Transient Ischemic Attack Patients in United States: Analysis of Nationwide Inpatient Sample 2006-2014	Disclosure: Dr. Nguyen has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	080	Personality traits and perception of health-related quality of life in people with multiple sclerosis: An analysis of the NEO-FFI-3 and MSIS-29 questionnaires	Disclosure: Dr. Meca Lallana has nothing to disclose.
Practice, Policy, and Ethics I
Start Time	Pub.	Title	Presenter
11:30 AM	081	Lack of childcare restricts work related travel for physician moms	Disclosure: Dr. Rauf has nothing to disclose.
MS Epidemiology, Co-Morbidities, and Modifiable Risk Factors
Start Time	Pub.	Title	Presenter
11:30 AM	081	Characteristics of Multiple Sclerosis Patients Treated With Disease-Modifying Therapies in Puerto Rico	Disclosure: Dr. Chia has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Sanofi.
11:30 AM	082	Disability Level and Comorbidity Burden among Multiple Sclerosis (MS) Patients in the US	Disclosure: Dr. Bartolome has nothing to disclose.
11:30 AM	083	MS race: How does speed affect our patients	Disclosure: Dr. Alonso has nothing to disclose.
11:30 AM	084	Modifiable Risk Factors and Risk of Disability Progression after a First Demyelinating Event: a Long Term Follow-Up Study	Disclosure: Dr. Dalla Costa has nothing to disclose.
11:30 AM	085	Benign Multiple Sclerosis - Recognition as a Defined Clinical Subtype	Disclosure: Dr. Yang has nothing to disclose.
11:30 AM	086	Multiple sclerosis mortality in patients from an Argentine cohort	Disclosure: Dr. Appiani has nothing to disclose.
11:30 AM	087	Updates to the National Institute of Neurological Disorders and Stroke (NINDS) Multiple Sclerosis (MS) Common Data Element (CDE) Recommendations: 2018 MS Oversight Committee (OC) Review	Disclosure: Dr. Gay has nothing to disclose.
11:30 AM	088	Multiple Sclerosis and Headache: A Further Examination of these Comorbid Conditions in Patients Receiving Care in a Multiple Sclerosis Center: A Cross-Sectional Study	Disclosure: Dr. Schaubhut has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Harry's Inc..
11:30 AM	089	Economic Burden of Multiple Sclerosis in Egypt – A Societal Perspective	Disclosure: Dr. Zakaria has nothing to disclose.
MS Special Populations: Pregnancy and Pediatrics
Start Time	Pub.	Title	Presenter
11:30 AM	090	No Evidence of Disease Activity in Pediatric-onset Multiple Sclerosis Patients Receiving Rituximab	Disclosure: Dr. Shukla has nothing to disclose.
11:30 AM	091	A Survey Study of Pregnancy-Related Issues in Multiple Sclerosis Patients: the Patient’s Voice.	Disclosure: Dr. Engel has nothing to disclose.
11:30 AM	092	Neurofilament Light Chain Levels In Pregnant Multiple Sclerosis Patients	Disclosure: Dr. Cuello has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen. Dr. Cuello has received research support from Biogen.
11:30 AM	093	The use natalizumab in multiple sclerosis patients during pregnancy is safe and prevents disease reactivation	Disclosure: Dr. Alroughani has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Bayer, Biogen, Biologix, Merck, Novartis, Roche and Sanofi. Dr. Alroughani has received research support from Biogen, Merck, Novartis, Roche and Sanofi.
11:30 AM	094	Anti CD20 Therapies and Pregnancy in Neuroimmunological Disorders – A Case Series from Germany	Disclosure: Dr. Kuempfel has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Bayer Healthcare, Teva Pharma, Merck, Novartis Pharma, Sanofi-Aventis/Genzyme, CLB Behring, Roche Pharma, Biogen, Bayer-Schering AG, and Chugai Pharma.
11:30 AM	095	Pregnancy Outcomes From an International Registry of Patients Treated With Delayed-release Dimethyl Fumarate	Disclosure: Dr. Everage has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen. Dr. Everage holds stock and/or stock options in Biogen, which sponsored research in which Dr. Everage was involved as an investigator. Dr. Everage holds stock and/or stock options in Biogen.
11:30 AM	096	Pregnancy outcomes in patients with multiple sclerosis and exposure to branded glatiramer acetate	Disclosure: Dr. Qassem has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Employee of Teva.
11:30 AM	097	Minimal concentrations of rituximab in the breastmilk of women treated for multiple sclerosis	Disclosure: Dr. LaHue has nothing to disclose.
11:30 AM	098	Obstructive Sleep Apnea in Pediatric Neuroinflammatory Conditions	Disclosure: Dr. Jaeggi has nothing to disclose.
11:30 AM	099	Comparison Of Continuous vs. Cyclic Oral Contraceptives in Women with Multiple Sclerosis	Disclosure: Dr. Chen has nothing to disclose.
11:30 AM	100	Pregnancy Outcome in Multiple SclerosisPatients Exposed to Disease ModifyingTherapies.	Disclosure: Dr. Ahmed has nothing to disclose.
11:30 AM	101	Pregnancy Outcomes from the Global Pharmacovigilance Database on Interferon Beta-1b Exposure	Disclosure: Dr. Hellwig has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Bayer, Biogen, Sanofi, Teva, Roche, Novartis, Merck. Dr. Hellwig has received research support from Bayer, Biogen, Merck, Novartis, Sanofi, Genzyme, Teva.
11:30 AM	102	Effects of Pregnancy on Specific Domains of Multiple Sclerosis Symptoms: A Quality Improvement Project at UPMC	Disclosure: Dr. Nayak has nothing to disclose.
11:30 AM	103	Rituximab for Treatment of Aggressive Multiple Sclerosis During Pregnancy: A Case Series	Disclosure: Dr. Rice has nothing to disclose.
11:30 AM	104	Diagnostic value of oligoclonal bands in children: A nationwide population-based cohort study	Disclosure: Dr. Spangsberg Boesen has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva, Novartis and Roche.
11:30 AM	105	Plasma Exchange and Natalizumab Rescue Therapy for Severe Intrapartum Multiple Sclerosis Relapses	Disclosure: Dr. Deasy has nothing to disclose.
11:30 AM	106	Grip Fatigability but not Strength Discriminates those with Pediatric Onset Multiple Sclerosis from Controls	Disclosure: Dr. Pilloni has nothing to disclose.

Ready to register for the 2019 AAN Annual Meeting?

Related Courses

Saturday, May 4, 2019
7:00 AM-9:00 AM
C1 - What Do I Do Now?: Assessment and Management of Neuropsychiatric Symptoms in Neurocognitive Disorders Daniel Kaufer MD, FAAN
C3 - Clinical EEG: Normal EEG, Normal Variants, and How to Avoid The Common Pitfall of Over-reading Selim Benbadis MD, FAAN
C4 - Pediatric Neuro-ophthalmology Update Christopher Glisson DO, FAAN
C6 - Therapy of Movement Disorders: A Case-based Approach David Riley MD
C7 - Clinical Pearls in Autoimmune Neurology: Real World Cases Stacey Clardy MD, PhD
C8 - Cognitive Psychology of Neurologic Errors: Why Do Neurologists Make Errors? Louis Caplan MD, FAAN
7:00 AM-12:30 PM
C9 - Clerkship and Program Directors Conference: Let’s Build an Educational Scholarly Product Zachary London MD, FAAN
8:00 AM-8:30 AM
Are you My Mentor? How to Select a Good Mentor for Your Research Center Deborah Hall MD, PhD, FAAN
9:00 AM-9:30 AM
What Should Applicants Look for in a Program? Adam De Havenon MD
How to Successfully Publish Quality Improvement Projects Anup Patel MD, FAAN
Trainee Experience: Navigating the AAN and Your Career
9:30 AM-11:30 AM
C12 - Clinical Approach to Muscle Disease I: Role of Antibodies, Muscle Imaging, and Genetic Testing Tahseen Mozaffar MD, FAAN
C13 - Clinicopathological Correlation Session in Dementia David Irwin MD
C14 - Child Neurology: Headache Amy Gelfand MD
C15 - Clinical EEG: Focal, Diffuse, and Epileptiform Abnormalities in Adults Katherine Noe MD, PhD, FAAN
C16 - Cerebrovascular Disease I: Prevention Larry Goldstein MD, FAAN, FAHA
C18 - Cerebellar and Afferent Ataxias: Diagnosis and Management Massimo Pandolfo MD, FAAN
C19 - Multiple Sclerosis Overview I: Clinical Pearls Mary Willis MD
C20 - Neurologic Complications of Medical Disease Sara Hocker MD, FAAN
C21 - Tick-based Infections Marie Grill MD
10:00 AM-10:30 AM
Quality Improvement Research in Neurology Mona Bahouth MD
11:00 AM-11:30 AM
Your CV Is Talking About You Behind Your Back and Your LORs Are, Too! Na Tosha Gatson MD, PhD
11:00 AM-11:45 AM
How to Become a Leader in Your Health System Lyell Jones MD, FAAN, Eric Cheng MD, MS, FAAN
Fellowship as a Springboard to Junior Faculty Kathryn Nevel MD
12:00 PM-12:30 PM
Navigating the Annual Meeting App Carlayne Jackson MD, FAAN
12:00 PM-3:30 PM
Futures in Neurological Research Boot Camp Deborah Hall MD, PhD, FAAN
12:00 PM-4:00 PM
C22 - Resident Basic Science I: Neuropathology J. Clay Goodman MD, FAAN
C24 - Leadership Challenges in Practice Brad Klein MD, MBA, FAAN
1:00 PM-1:30 PM
Statistics: Sample Size William Meurer MD
1:00 PM-1:45 PM
Tips and Tools for Successful Recruitment Peggy Nolty
What's Going On With E/M? Luana Ciccarelli , Bruce Cohen MD, FAAN
1:30 PM-3:30 PM
C25 - Clinical Approach to Muscle Disease II: Inflammatory Myopathies and Muscle Pathology Tahseen Mozaffar MD, FAAN
C26 - Clinical EEG: Neonatal and Pediatric Nicholas Abend MD
C27 - Cerebrovascular Disease II: Update on Guidance-Based Diagnosis and Management of Hemorrhagic Stroke Andrew Naidech MD, FAAN
C34 - Evaluating Tremor in the Office Andres Deik Acosta Madiedo MD
C29 - Multiple Sclerosis Overview II: Clinical Advances Scott Newsome DO, FAAN
C30 - Neurologic Complications of Medical and Surgical Therapies Sara Hocker MD, FAAN
C31 - Mitochondrial Disorders in Neurology Michio Hirano MD, FAAN
C32 - The Neurology of Social Behavior Bradford Dickerson MD, FAAN
C33 - Teleneurología (Teleneurology) Susana Bowling MD
1:30 PM-4:00 PM
C35 - Educators' Leadership Program (Registration Required) Rana Said MD, FAAN
1:45 PM-2:30 PM
The Experience of Music Therapy in the Interdisciplinary Treatment of TBI Rebecca Vaudreuil EdM, MT-BC, Renee Pazdan MD, FAAN
2:00 PM-2:45 PM
A Career in Neuroimaging Michael Hutchinson MD, PhD
2:30 PM-3:15 PM
Dancing with Parkinson's Diviya Kaul MD
2:45 PM-3:30 PM
Case Studies: Ethical Conundrums in Neurology Justin Sattin MD, Winston Chiong MD, Ariane Lewis MD, Salvador Cruz-Flores MD, FAAN, William Graf MD, FAAN, Daniel Larriviere MD, JD, FAAN, James Russell MD, MS, FRPC, FAAN
3:00 PM-3:45 PM
Using Technology to Get Real Answers from Your Patients Lidia Maria Moura MD, FAAN
Interventional Neurology: Training and Practice Adnan Qureshi MD
3:00 PM-4:00 PM
AAN Business Meeting
3:45 PM-4:45 PM
Women in Neurology Jennifer Bickel MD, FAAN, Veronica Santini MD, MA, Meeryo Choe MD, Renee Pazdan MD, FAAN
4:00 PM-4:45 PM
Opioids: What Is Your State Doing to Confront This Epidemic? Donn Dexter MD, FAAN
4:15 PM-5:30 PM
Hot Topics Plenary Session Eric Klawiter MD, FAAN
5:00 PM-5:30 PM
Trainee Experience: Navigating the AAN and Your Career
5:00 PM-5:45 PM
Telestroke Across the Continuum Amy Guzik MD
5:45 PM-6:45 PM
Advancing Medicine: Inspiration and Innovation Featuring Hugh Herr, PhD Hugh Herr PhD

Sunday, May 5, 2019
7:00 AM-7:30 AM
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-7:45 AM
Resident Evaluation of Faculty: A New Approach Deborah Fay
7:00 AM-9:00 AM
C46 - Actualización en dolor de cabeza y trastornos neuromusculares (Update: Headache and Neuromuscular Disorder) Jose Merino MD, MPhil, FAAN, Dario Beltran MD, FAAN
C36 - Mastering EMG Waveform Recognition Skills in Just Two Hours! Devon Rubin MD, FAAN
C37 - Chronic Traumatic Encephalopathy: Update Andrew Budson MD
C38 - Infections of the Nervous System I: Diagnostic Testing of Neurological Infections Tracey Cho MD, FAAN
C39 - How to Design Meaningful Clinical Trials Laurie Gutmann MD, FAAN
C40 - Child Neurology: Stroke Lori Billinghurst MD
C42 - The Dystonias: Diagnosis, Treatment and Update on Etiologies Rachel Saunders-Pullman MD
C43 - Residents in Private Practice Anil Dhuna MD, FAAN
C44 - Multiple Sclerosis Therapy: Symptom Management Andrew Solomon MD, FAAN
C45 - Status Epilepticus Stephan Schuele MD, FAAN
8:00 AM-8:30 AM
C260 - Accreditation Step by Step: From Self Study to Site Visit Crys Draconi
Neuroscience of Bias Jose Posas MD
Clerkship Director Conversation Rachel Marie Salas MD, FAAN
8:00 AM-8:45 AM
Coding for Residents Kavit Shah MD
8:30 AM-9:00 AM
C261 - How to Become An Advocate For Yourself and Your Program Sana Ghafoor MD
Neuroscience Course Director Conversation Peter Hannon MD, Madhu Soni MD, FAAN
9:00 AM-10:00 AM
C262 - Choosing, Training, Forging, and Mentoring Chief Residents: Program Coordinator Role Marla Scofield C-TAGME
9:15 AM-12:00 PM
Presidential Plenary Session Natalia Rost MD, MPH, FAAN, FAHA
11:30 AM-6:30 PM
P1 - Poster Session 1
12:00 PM-12:45 PM
Almuerzo con Colegas: Perlas clínicas/ solicitando una residencia o subespecialidad en neurología
12:00 PM-1:00 PM
Neurology Pictionary Bert Vargas MD, FAAN
Meet and Greet with the Pennsylvania Neurological Society Amtul Farheen MD, FAAN, Anthony May MD
Meet and Greet with the Pennsylvania Neurological Society Anthony May MD, William Jens DO, Elliott Schulman MD, FAAN, Brad Klein MD, MBA, FAAN, Amtul Farheen MD, FAAN, Parthasarathy Thirumala MD, FAAN, David Tabby DO, FAAN, Jyoti Pillai MD, MBBS, MR, FAAN, Tara Morrison MD, FAAN
1:00 PM-1:45 PM
Tip of the Iceberg: Ultra-high Cost Neurology Drugs Nicholas Johnson MD, FAAN
1:00 PM-2:15 PM
S1 - Neuroepidemiology
1:00 PM-3:00 PM
C60 - Assessment of Rapidly Progressive Dementias I: Prion and Non-prion Neurodegenerative Diseases Michael Geschwind MD, PhD, FAAN
C48 - Infections of the Nervous System II: Neuro-ID Emergencies Tracey Cho MD, FAAN
C49 - Neurology Update I: Multiple Sclerosis, Sleep, and Neuromuscular Disease Ralph Jozefowicz MD, FAAN, Adam Quick MD
C50 - Cerebrovascular Disease III: Update on Neuroimaging Modalities and Endovascular Therapies for Acute Ischemic Stroke Johanna Fifi MD
C51 - Balance and Gait Disorders Alfonso Fasano MD, PhD
C52 - Introduction to Integrative Neurology Sarah Mulukutla MD, MPH
C53 - Introduction to Primary Headache Disorders: Migraine and Other Primary Headaches Including Tension-Type, Hypnic, Primary Stabbing and Nummular Headache Syndromes, Epicrania Fugax and Retinal Migraine Deborah Friedman MD, MPH, FAAN
C56 - Multiple Sclerosis Therapy: Disease-modifying Treatment I Scott Newsome DO, FAAN
C57 - Drugs and Toxin-induced Neurologic Emergencies Sara Hocker MD, FAAN
C58 - Business Strategies for Payer Negotiations and/or How to Go off the Grid Joseph Fritz PhD
C47 - Evaluation and Management of Autonomic Disorders I: Autonomic Testing, Failure, and Peripheral Neuropathies Amanda Peltier MD, MS
S3 - Epilepsy/Clinical Neurophysiology (EEG) I
S5 - Therapeutics in ALS and SMA
S4 - Clinical Trials in Movement Disorders
S6 - MS and CNS Inflammatory Disease: Clinical Considerations I
IS1 - Invited Science: Infectious Diseases and Global Health John England MD, FAAN, Kiran Thakur MD
1:00 PM-5:00 PM
Consortium of Neurology Program Directors Business Meeting Zachary London MD, FAAN, Jaffar Khan MD, FAAN, Erica Schuyler MD
1:00 PM-5:30 PM
C64 - Skills Workshop: Neurophysiologic Intraoperative Monitoring (Registration Required) Aatif Husain MD
C63 - Resident Basic Science II: Neuropharmacology James Owens MD, PhD
1:30 PM-2:30 PM
AAN Leadership: Using Experiences to Answer the Tough Questions Robert Griggs MD, FAAN, Stephen Sergay MB BCh, FAAN, Terrence Cascino MD, FAAN, Ralph Sacco MD, MS, FAHA, FAAN, Sandra Olson MD, FAAN, Roger Rosenberg MD, FAAN, Stanley Fahn MD, FAAN, Francis Kittredge MD,FAAN
2:00 PM-2:30 PM
SIGN Faculty Advisor Conversation Yolanda Reyes-Iglesias MD
2:00 PM-2:45 PM
Teaching the Next Generation of Physician Advocates: Advocacy Curriculum for Neurology Residents Kara Stavros , Jonathan Cahill MD
Navigating a Career in Academics Joseph Safdieh MD, FAAN, Jennifer Molano MD, FAAN
3:00 PM-3:45 PM
Practice Innovation in Epilepsy Anup Patel MD, FAAN
Lost in Translation: Acknowledging and Respecting Cultural Differences With Your Patients Jose Merino MD, MPhil, FAAN, Joseph Sirven MD, FAAN
Education Research: The Secret Sauce to Career Advancement as Clinician Educator Andrew Southerland MD
3:30 PM-5:30 PM
C76 - Assessment of Rapidly Progressive Dementias II: Infections and Autoimmune Mediated Conditions Michael Geschwind MD, PhD, FAAN
C66 - Infections of the Nervous System III: Advanced Topics in Infectious Neurology Tracey Cho MD, FAAN
C67 - Neurology Update II: Behavioral Neurology, Movement Disorders, and Neuro-ophthalmology Ralph Jozefowicz MD, FAAN, Adam Quick MD
C68 - Cerebrovascular Disease IV: Telestroke Eric Anderson MD, PhD
C70 - Introduction to Primary Headache Disorders: Trigeminal Autonomic Cephalalgias and Other Primary Headaches Including New Daily Persistent Headache, Cough, Exercise, and Thunderclap Headaches Christopher Boes MD, FAAN
C72 - Disordered Sleep in Common Neurologic Diseases: Traumatic Brain Injury, Stroke, and Parkinson’s Disease LynnMarie Trotti MD
C73 - Multiple Sclerosis Therapy: Disease-modifying Treatment II John Rose MD, FAAN
C74 - CNS Toxicities Neeraj Kumar MD
C75 - How to Run a Practice: Business Strategies for Neurology Private Practices and the Future David Evans MBA
C65 - Evaluation and Management of Autonomic Disorders II: Diagnostic Approach and Treatments for Dysautonomia Amanda Peltier MD, MS
N1 - Neuroscience in the Clinic: Child Neurology: Emerging Understanding of the Epilepsy-Movement Disorder Spectrum Across the Lifespan Deborah Hall MD, PhD, FAAN, Erika Augustine MD, FAAN
S9 - Aging and Dementia: Clinical Trials and Novel Therapies
S10 - Biomarkers in Movement Disorders
4:00 PM-4:45 PM
Navigating Prior Authorizations Pearce Korb MD, FAAN
Living an Alpha Brain Wave Life: Work/Life Balance Tamika Burrus MD, FAAN
4:15 PM-5:00 PM
The Teenage Brain: Neuroscience You Can Use Frances Jensen MD, FAAN
5:00 PM-5:30 PM
Trainee Experience: Navigating the AAN and Your Career
5:00 PM-5:45 PM
Remote and Team-based Care Jeffrey Buchhalter MD, FAAN, Raghav Govindarajan MD, FAAN, Anup Patel MD, FAAN, Calli Cook DNP, APRN, FNP-C
How to Be a Teacher as a Resident Jeremy Cutsforth-Gregory MD
5:15 PM-6:15 PM
Standing on the Shoulders of Giants Cynthia Comella MD, FAAN

Monday, May 6, 2019
7:00 AM-7:30 AM
Tips to Sail Through the IRB Deborah Hall MD, PhD, FAAN
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-8:45 AM
Clerkship Administrators Certification Program Celia Linton
7:00 AM-9:00 AM
C78 - Young Onset and Atypical Alzheimer's Dementia Jonathan Graff-Radford MD
C79 - Differential Diagnosis of Neurologic Infections Michael Wilson MD, FAAN
C80 - Epileptologists’ Secrets for the Busy General Neurologist: Localization, Imaging, and Fear of Surgery Carol Ulloa MD
C82 - Stroke in Young Adults and Women Aneesh Singhal MD, FAAN
C83 - Diagnosis and Treatment of Functional Movement Disorders Mark Hallett MD, FAAN
C85 - Severe TBI: From ICU to Rehabilitation Susanne Muehlschlegel MD, MPH, FAAN
C86 - Neuromyelitis Optica Spectrum Disorders Dean Wingerchuk MD, FAAN
C87 - Skills Workshop: Clinical Usefulness of Botulinum Toxin for Spasticity (Registration Required) Allison Brashear MD, MBA, FAAN
7:30 AM-9:00 AM
Student Interest Group in Neurology (SIGN) Meeting Madhu Soni MD, FAAN
8:00 AM-8:45 AM
Physical Exercise and Cognitive Training in Neurology-Application in Aging & Neurodegenerative Disease Ergun Uc MD
Personal Finances for Residents Brad Klein MD, MBA, FAAN
8:00 AM-9:00 AM
Updating the NIH BRAIN Initiative: A Dialogue with the AAN Walter Koroshetz MD, FAAN
8:30 AM-9:00 AM
Residency Program Director Conversation Rana Said MD, FAAN
9:15 AM-12:00 PM
Contemporary Clinical Issues Plenary Session Randolph Marshall MD, FAAN
11:30 AM-6:30 PM
P2 - Poster Session 2
11:45 AM-12:30 PM
Self-management in Neurologic Disease Lisa Shulman MD, FAAN, Barbara Jobst MD, FAAN
12:00 PM-12:45 PM
Training in Research for Academic Neurologists to Sustain Careers and Enhance the Numbers of Diverse Scholars (TRANSCENDS) Program Bruce Ovbiagele MD, MSc, FAAN
LGBTQ+ Health in Neurology - Why It's Important and What You Need to Know Nicole Rosendale MD
12:00 PM-1:00 PM
Would You Fly With This Pilot? Joseph Sirven MD, FAAN
Meet a Member of Congress: U.S. Representative Brendan Boyle (D-PA) Brendan Boyle
1:00 PM-1:30 PM
Diversity Officer Roundtable Discussion Roy Hamilton MD, MS, FAAN
1:00 PM-1:45 PM
Controversies in Neuroimaging James Burke MD, James Johnston MD, JD
1:00 PM-2:00 PM
Advancing Medicine: Inspiration and Innovation Featuring Mona Hanna-Attisha, MD, MPH, FAAP Mona Hanna-Attisha MD, MPH, FAAP
1:00 PM-3:00 PM
C88 - Mild Cognitive Impairment: Implications for Clinicians Ronald Petersen PhD, MD, FAAN
C101 - Clinical EMG I: Principles and Practice of NCS and Needle EMG Ruple Laughlin MD, FAAN
C89 - Tuberculosis of the Central Nervous System Jerome Chin MD, PhD, MPH, FAAN
C90 - Clinical Epilepsy I: Basics Tracey Milligan MD, FAAN
C91 - Neurology Update III: Headache, Neuro-otology, and Epilepsy Ralph Jozefowicz MD, FAAN, Adam Quick MD
C92 - Autism Spectrum Disorders What We Know and Where We Are Going Rujuta Wilson MD
C93 - Paroxysmal Movement Disorders Kailash Bhatia MD, FAAN
C97 - Neuroendocrine Update: Nuts and Bolts of What You Need to Know Alison Pack MD
C98 - Faculty Development: Enhancing Your Role in Student and Resident Training Vicki Shanker MD
C99 - Starting a Practice From the Ground Up: A Guide for Early Career Neurologists Brad Klein MD, MBA, FAAN
C100 - Esclerosis Múltiple y Otras Enfermedades Inflamatorias Desmielinizantes y Autoinmunes del Sistema Nervioso Central (MS and Other Demyelinating Inflammatory and Autoimmune Central Nervous System Disorders) Lilyana Amezcua MD, FAAN
N2 - Neuroscience in the Clinic: Interpretations of Genetic Results Massimo Pandolfo MD, FAAN, Karen Marder MD, MPH, FAAN
S12 - Progressive Multiple Sclerosis
S13 - Behavioral and Cognitive Neurology: Behavioral Neurology, Aging, and Dementia
S15 - Intracerebral Hemorrhage and SAH
S16 - Huntington's Disease: From Bench to Clinical Trials
S17 - Headache: Clinical Trials I
1:00 PM-5:30 PM
C103 - Resident Basic Science III: Neuroanatomy: All the Lesions Zachary London MD, FAAN
C105 - Skills Workshop: Clinical Uses of Botulinum Toxin for Dystonia (Registration Required) Diego Torres-Russotto MD, FAAN
C104 - Research Career Symposium Chad Hales MD, PhD, FAAN
1:30 PM-2:30 PM
Blind Spots: The Impact of Conscious and Unconscious Biases Jeffrey McClean MD, FAAN, Charles Flippen MD, FAAN, Laraine Kaminsky
2:00 PM-2:45 PM
Using EHR to Close Referral Loops Melissa Yu MD, FAAN, Allison Weathers MD, FAAN, Allan Wu MD
A Career in Clinical Practice Stephen Sergay MB BCh, FAAN
2:00 PM-3:00 PM
ABPN Continuing Certification Information Session J. Clay Goodman MD, FAAN, A. Gordon Smith MD, FAAN
2:30 PM-3:15 PM
The Role of Integrative Medicine in Epilepsy Ann Marie Collier MD
2:45 PM-3:00 PM
Kenneth M. Viste, Jr., MD Patient Advocate of the Year Awards Glenn Graham MD, PhD, FAAN
2:45 PM-3:30 PM
Self Reflected: Deeply Fusing Art and Science to Create the World's Most Complex Artistic Depiction of the Human Brain Greg Dunn PhD
3:00 PM-3:45 PM
Research Outputs from the Axon Registry Lyell Jones MD, FAAN
Child Neurology for Trainees Rana Said MD, FAAN
3:30 PM-4:00 PM
Residency Program Director Conversation Emily Pharr MD
3:30 PM-4:45 PM
S18 - Autonomic Disorders
3:30 PM-5:30 PM
C120 - Clinical EMG II: Case-based Clinical Applications of Nerve Conduction Studies and Needle Electromyography Ruple Laughlin MD, FAAN
C106 - Cognitive Impairment Due to Alzheimer's Disease: Using Old Skills and New Tools for Diagnosis and Treatment David Knopman MD, FAAN
C108 - Clinical Epilepsy II: Considerations Across the Age Span: Pediatrics, Pregnancy, and Elderly Barbara Jobst MD, FAAN
C109 - Neurology Update IV: Stroke, Neuro-infectious Disease, and Autoimmune Encephalopathies Ralph Jozefowicz MD, FAAN, Adam Quick MD
C115 - Emerging Approaches to Biosensing for the Diagnosis and Management of Neurological Disease John Hixson MD
C116 - LGBTQI Health in Neurology Holly Hinson MD, MCR, FAAN
C117 - Tourette Syndrome: Assessment and Management Tamara Pringsheim MD, FAAN
C118 - How to Understand and Incorporate Medical Cannabis into Clinical Practice Laszlo Mechtler MD, FAAN, FASN
C119 - Actualización en lesión cerebral traumática e ictus isquémico (Update: TBI and Stroke) Dario Beltran MD, FAAN, Jose Merino MD, MPhil, FAAN
S19 - Child Neurology: Updates in Autism, Migraine, MS, and Stroke
S20 - Headache Imaging and Physiology and Episodic Syndromes Associated with Migraine
S22 - Stroke Genetics, Cellular Responses, and Animal Models
S23 - Genetic Muscle Disorders
Presentation of the Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases
3:45 PM-4:45 PM
Philadelphia: The City of Neurology Love Christopher Goetz MD, FAAN, Stephen Reich MD, FAAN, Frances Jensen MD, FAAN, Donald Silberberg MD,FAAN
4:00 PM-4:30 PM
Clerkship Director Conversation Holli Horak MD, FAAN
4:00 PM-4:45 PM
#MeanReviews: Flipping Imposter Syndrome on Its Head Rachel Marie Salas MD, FAAN
4:30 PM-5:00 PM
Everything You Wanted to Know About the Neurology® Resident & Fellow Section John Millichap MD, FAAN
5:00 PM-5:30 PM
Trainee Experience: Navigating the AAN and Your Career
Residency Program Director Conversation Erica Schuyler MD
5:00 PM-5:45 PM
Defining, Evaluating, and Promoting Healthy Cognitive Aging Kirk Daffner MD, FAAN
Safety and Quality Awards Amy Sanders MD, FAAN, Anup Patel MD, FAAN
Careers in Movement Disorders Stanley Fahn MD, FAAN
5:00 PM-6:00 PM
Standing on the Shoulders of Giants Kenneth Heilman MD, FAAN

Tuesday, May 7, 2019
7:00 AM-7:30 AM
Diversifying Your Funding Sources with NIH and Other Sources Ana-Claire Meyer MD
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-7:45 AM
Pursuing a Career in Industry Brandy Matthews MD, FAAN
7:00 AM-9:00 AM
C121 - Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches Mark Bromberg MD, PhD, FAAN
C123 - Child Neurology: Genetic and Metabolic Testing in Pediatric Epilepsy James Riviello MD
C122 - Neurocognitive Assessment for Neurologists Mario Mendez MD, PhD, FAAN
C124 - Endovascular Treatment of Acute Stroke and Cerebrovascular Disease Dileep Yavagal MD, FAAN
C126 - Active Management of Professionalism Lapses: A New Way of Thinking Ann Poncelet MD, FAAN
C127 - Hyperkinetic Movement Disorders: Videodiagnosis and Treatment Steven Frucht MD
C129 - Critical Care Consultations for Neurohospitalists Vanja Douglas MD
C130 - Diagnostic Pearls in Myelitis: a Case-based Approach Eoin Flanagan MBBCh
7:30 AM-9:00 AM
C263 - Access: Strategies to Improve Access in Academic Medicine Jaya Trivedi MD, FAAN
8:00 AM-8:45 AM
Advocacy for Residents Kara Stavros
Welcome to NIH Day/Overview of NIH Funding with NINDS Director and NIA Director, Division of Neuroscience Walter Koroshetz MD, FAAN
9:15 AM-11:30 AM
Clinical Trials Plenary Session Deborah Hall MD, PhD, FAAN, Holly Hinson MD, MCR, FAAN
11:30 AM-6:30 PM
P3 - Poster Session 3
11:45 AM-12:45 PM
Emerging Science Session
12:00 PM-12:30 PM
Learn About Opportunities to Work with the NIH Intramural Program Avindra Nath MD, MBBS, FAAN
12:00 PM-12:45 PM
Optimizing Communication in Difficult Patient Relationships Veronica Santini MD, MA
12:00 PM-1:00 PM
Neuro Game Show: Localize the Lesion Luis Torres MD
12:30 PM-1:00 PM
NIH Grant Review Process Shanta Rajaram PhD
1:00 PM-1:45 PM
Women in Neurology: Thriving Through Challenges Divya Singhal MD, FAAN, Kathrin LaFaver MD, FAAN
K Awards and Training Programs – Planning for a Career as an NIH Investigator Nina Schor MD, PhD, FAAN
1:00 PM-3:00 PM
C132 - Frontotemporal Dementias Elizabeth Finger MD, FAAN
C131 - Small Fiber Neuropathies: Sensory, Autonomic, and Both I: Focus on Autonomic Nervous System Christopher Gibbons MD, FAAN
C133 - Clinical Epilepsy III: Advanced (Status, Beyond AED, Video EEG) William Tatum DO, FAAN
C135 - Case Studies: Challenging Acute Ischemic Stroke Cases Vivien Lee MD, FAAN
C136 - Neuroimaging for the General Neurologist I: Brain Joshua Klein MD, PhD, FANA, FAAN, Ligia Onofrei MD
C137 - Deep Brain Stimulation I: Basic Principles and Programming in Movement Disorders Michael Pourfar MD
C138 - Hot Topics in Headaches and Related Disorders I: Unusual Headaches, Childhood Headaches, and Concussion Management Amy Gelfand MD
C142 - Autoimmune Neurology I Basics and Beyond: Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes of the CNS and PNS Stacey Clardy MD, PhD
C143 - Education Research Methodology Course Andrew Southerland MD
N3 - Neuroscience in the Clinic: Stem Cells Antonio Omuro MD, Paul George MD, PhD, MSE
C144 - Actualización científica I (Scientific Update I - Spanish) Edgar Samaniego MD
S25 - Child Neurology: Spinal Muscular Atrophy: Treatments and Outcomes
S26 - MS and CNS Inflammatory Disease: Clinical Considerations II
S27 - General Neurology: Improving Neurologic Care and the Impact of Therapeutics
C264 - Division Chief's Round Table: Maximizing Effectiveness and Addressing Challenges Claire Henchcliffe MD, PhD, FAAN
1:00 PM-5:30 PM
C148 - Skills Workshop: EMG: Basic (Registration Required) Holli Horak MD, FAAN
1:30 PM-2:30 PM
Neuro Exam Tricks and Tips Ludwig Gutmann MD, FAAN, Laurie Gutmann MD, FAAN, Nancy Newman MD, FAAN
1:45 PM-2:15 PM
NIH Funding and Professional Development Opportunities for Diverse Researchers Michelle Jones-London PhD
2:00 PM-2:45 PM
The HSR Game Show Gregory Esper MD, MBA, FAAN, Jason Sico MD, FAAN
A Career in Teleneurology: A Panel Discussion Eric Anderson MD, PhD
2:15 PM-3:00 PM
Clinical Trials and Networks – NeuroNEXT, StrokeNET, SIREN; Alzheimer’s Clinical Trials Consortium Clinton Wright MD, FAAN
3:00 PM-3:45 PM
The New Congress: How Will It Impact Neurology Nicholas Johnson MD, FAAN, James Goldenberg MD, FAAN
Live Intraoperative Monitoring Constantine Moschonas MD, FAAN
Oportunidades de colaboración internacional para realizar proyectos de investigación en enfermedades neurodegenerativas (Opportunities for International Collaborations to Conduct Research on Neurodegenerative Diseases) Yakeel Quiroz PhD
AD/ADRD Opportunities Clinton Wright MD, FAAN
3:30 PM-4:00 PM
Writing and Reviewing for the Neurology® Resident & Fellow Section John Millichap MD, FAAN
3:30 PM-5:30 PM
C150 - Small Fiber Neuropathies: Sensory, Autonomic, and Both II: Focus on Sensory Nervous System Christopher Gibbons MD, FAAN
C151 - Lewy Body Dementias Karen Marder MD, MPH, FAAN
C164 - Update on Medical Management of Stroke Adam De Havenon MD
C154 - Neuroimaging for the General Neurologist II: Brain Shamik Bhattacharyya MD, Joshua Klein MD, PhD, FANA, FAAN
C155 - Deep Brain Stimulation II: Advanced Management in Movement Disorders and Applications Beyond Movement Disorders Leonard Verhagen Metman MD, PhD
C156 - Hot Topics in Headaches and Related Disorders II: Migraine Pathophysiology, Brain Imaging, and Therapeutic Advances Andrew Charles MD
C159 - Mid-Level Faculty Career Development Course Deborah Hall MD, PhD, FAAN
C160 - Autoimmune Neurology II Advanced: Autoimmune Encephalitis at the Frontiers of Neuroscience Eoin Flanagan MBBCh
C161 - Child Neurology: Metabolic Marc Patterson MD, FAAN, FRACP
C152 - Clinical Epilepsy IV: Surgery Gregory Cascino MD, FAAN
C163 - Creating a Roadmap for a Diverse Workforce in Academic Neurology Nimish Mohile MD, FAAN, Roy Hamilton MD, MS, FAAN
C162 - Coding 101: E&M, Basic Procedures, Non Face-to-Face, and New Codes Bruce Cohen MD, FAAN
C149 - Clinical Neurology for Advanced Practice Providers Jessica Erfan PA-C
S29 - NeuroHIV: Pathophysiology and Clinical Phenotypes
S31 - MS and CNS Inflammatory Disease: Imaging
S32 - General Neurology: Advances in Neurology: From the Clinic to the Bench
IS2 - Invited Science: Movement Disorders Deborah Hall MD, PhD, FAAN
Presentation of the Sheila Essey Award: An Award for ALS Research
3:45 PM-4:30 PM
HEAL Initiative - Pain Research Funding Opportunities, Clinical and Basic Michael Oshinsky PhD
4:00 PM-4:45 PM
So You've Had an EHR for 10 Years, Now What? Allison Weathers MD, FAAN, Allan Wu MD, Melissa Yu MD, FAAN
Healthcare Disparities in Populations Alejandro Vargas MD, Sharon Lewis MD, Jeffrey McClean MD, FAAN, Brett Kissela MD, FAAN, MS
Not Dead Yet: How to Remain Relevant and Engaged in Mid to Late Career Heidi Schwarz MD, FAAN
4:30 PM-5:00 PM
Translational Research Amir Tamiz
Using the Neurology® Resident & Fellow Section John Millichap MD, FAAN
5:00 PM-5:30 PM
Trainee Experience: Navigating the AAN and Your Career
5:00 PM-5:45 PM
What Is the Neurologist Compensation and Productivity Survey and How Can It Increase My Value? David Evans MBA, Michael Markowski DO, FAAN
From Private Practice to Academics Sarah Benish MD, FAAN
5:00 PM-6:00 PM
Standing on the Shoulders of Giants Nancy Newman MD, FAAN

Wednesday, May 8, 2019
7:00 AM-7:30 AM
How to Write and Publish Research Papers, Reviews, and Other Scientific Communication Mark Hallett MD, FAAN
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-7:45 AM
Simulation in Neurology Education Arielle Kurzweil MD, Ariane Lewis MD, Aaron Nelson MD
7:00 AM-9:00 AM
C165 - Current Management of Incidental and Asymptomatic Cerebrovascular Lesions Robert Brown MD, FAAN
C166 - Neuroimaging Biomarkers Across the Dementia Spectrum Liana Apostolova MD, FAAN
C168 - Parkinson's Disease Update Melissa Nirenberg MD, PhD, FAAN
C170 - Video EEG: Name That Spell Amy Crepeau MD
C171 - Child Neurology: Neuromuscular/Autoimmune Neurology Anne Connolly MD, FAAN
C172 - Advances in Neurogenetics Matthew Harms MD
C173 - Skills Workshop: Practical Training in Injection Techniques in the Treatment of Headache Disorders (Registration Required) Amaal Starling MD, Rashmi Halker Singh MD, FAAN
8:00 AM-8:30 AM
Recruiting Underrepresented Populations into Trials Temitayo Oyegbile MD, PhD
8:00 AM-8:45 AM
Complementary Therapies in Parkinson's Disease Veronica Santini MD, MA
Contract Negotiations for Residents Eva Ritzl MD, FAAN
Consejos prácticos para educadores médicos (Practical Advice for Medical Educators) Yazmin Odia MD, FAAN, MS
8:00 AM-9:00 AM
C265 - Using the Neurology Compensation and Productivity Survey in the Academic Setting Melissa Yu MD, FAAN, J. Barnes MBA
8:30 AM-9:00 AM
Neuroscience Course Director Conversation Madhu Soni MD, FAAN
9:15 AM-11:30 AM
Frontiers in Neuroscience Plenary Session Paul George MD, PhD, MSE
11:00 AM-11:30 AM
Resident and Fellow Conversation Abhimanyu Mahajan MD
11:30 AM-6:30 PM
11:45 AM-12:30 PM
Eating Your Way to Fewer Migraines Belinda Savage-Edwards MD, FAAN, Chef Tess Connor
12:00 PM-12:45 PM
Funding Clinically Oriented/Translational Research Before R01 – Consortium and Foundation Opportunities Aasef Shaikh MD
12:00 PM-1:00 PM
Neuro-Jeopardy: Telencephalon Twisters Laurice Yang MD, MHA, Veronica Santini MD, MA
1:00 PM-1:45 PM
Understanding the AAN's Latest Guidelines Tamara Pringsheim MD, FAAN
Headache Neuromodulation Therapy Heidi Schwarz MD, FAAN
Teaching Neurologic Competency Competently Despite the Competencies: A.B. Baker Award for Lifetime Achievement in Neurologic Education Keynote Address Steven Lewis MD, FAAN
1:00 PM-2:00 PM
Advancing Medicine: Inspiration and Innovation Featuring Patricia Churchland, PhD Patricia Churchland PhD
1:00 PM-3:00 PM
C175 - Neuromuscular Junction Disorders I: Myasthenia Gravis, Ocular, and MuSK Myasthenia Laura Tormoehlen MD, FAAN
C176 - Behavioral Neurology I: Network Anatomy of Behavior and Language Maria Gorno Tempini MD, PhD
C177 - Maximizing Quality of Life in Stroke, ALS, Parkinson’s Disease, and Dementia: A Palliative Approach Maisha Robinson MD, MS
C178 - Therapy in Neurology I: Neurological Infectious Diseases and Neuro-oncology Madhu Soni MD, FAAN
C179 - Nonmotor Manifestations of Parkinson's Disease I Jennifer Goldman MD, MS, FAAN
C187 - Comprehensive Migraine Update I: Migraine Diagnosis, Pathophysiology, and Comorbidities Gretchen Tietjen MD
C181 - Treatment of Pediatric Multiple Sclerosis in the Current Era Brenda Banwell MD, FAAN
C182 - Neuroimaging for the General Neurologist: Spine J. D. Bartleson MD, FAAN, Felix Diehn MD
C183 - Reading, Critiquing, and Reviewing the Neurologic Literature: An Evidence-based Approach and Case-based Presentation of Peer Reviews in Neurology Roy Strowd MD
C184 - Business Efficiencies for Academic Neurology Departments: Business Strategies for Success Gregory Esper MD, MBA, FAAN, Lyell Jones MD, FAAN
C185 - Actualización en trastornos del movimiento (Update in Movement Disorders) Andres Deik Acosta Madiedo MD
C186 - Women Founders of Neurology and Neuroscience I Stefano Sandrone PhD
N4 - Neuroscience in the Clinic: Immunotherapies in Neurological Disease Holly Hinson MD, MCR, FAAN, John Corboy MD, FAAN
S34 - Aging and Dementia: Risk Factors, Biomarkers, and Neuropathology
S35 - Stroke Prevention Strategies
S36 - Epilepsy/Clinical Neurophysiology (EEG) II
S37 - MS Biomarkers
S38 - Headache: Clinical Trials II
1:00 PM-5:30 PM
C190 - Skills Workshop: Neurostimulation (Registration Required) David Spencer MD, FAAN
C191 - Skills Workshop: Neuromuscular Ultrasound (Registration Required) Craig Zaidman MD
1:30 PM-2:30 PM
The Zoo Called - You Have a Consult Ann Tilton MD, FAAN
2:00 PM-2:45 PM
Being a Neurologist at a VA Hospital Jason Sico MD, FAAN
3:00 PM-3:45 PM
Foundations in Success in the AAN Holly Hinson MD, MCR, FAAN, Jeffrey McClean MD, FAAN, Ann Tilton MD, FAAN, Orly Avitzur MD, MBA, FAAN, Terrence Cascino MD, FAAN, Michael Markowski DO, FAAN, Christine Phelps
Understanding the AAN's Toolkit for Advanced Practice Providers Calli Cook DNP, APRN, FNP-C
How to Successfully Incorporate APPs into Your Practice James Stevens MD, FAAN
3:30 PM-5:30 PM
C192 - Neuromuscular Junction Disorders II: Toxins, Lambert-Eaton Syndrome and Less Common Disorders of Neuromuscular Transmission Laura Tormoehlen MD, FAAN
C193 - Behavioral Neurology II: Memory and Attention Maria Gorno Tempini MD, PhD
C195 - Therapy in Neurology II: Neurocritical Care and Neuromuscular Disease Madhu Soni MD, FAAN
C194 - CANCELED Faculty
C196 - Nonmotor Manifestations of Parkinson's Disease II Jennifer Goldman MD, MS, FAAN
C203 - Comprehensive Migraine Update II: Pharmacologic and Non-Pharmacologic Therapies Gretchen Tietjen MD
C198 - Integrating Sleep Medicine Concepts into Your Child Neurology Practice Suresh Kotagal MD, FAAN
C199 - Neuroimaging for the General Neurologist: Peripheral Nerve Kimberly Amrami MD, J. D. Bartleson MD, FAAN
C200 - Neurologic Case Studies in Pregnancy Amy Hessler DO, FAAN
C201 - Academic Neurology Departments 2020 and Beyond: Succeeding in the Tripartite Mission Lyell Jones MD, FAAN, Gregory Esper MD, MBA, FAAN
C202 - Women Founders of Neurology and Neuroscience II Stefano Sandrone PhD
N5 - Neuroscience in the Clinic: Wearable Technology Eric Klawiter MD, FAAN, Deborah Hall MD, PhD, FAAN
S39 - Education Research and Research Methodology
S40 - Stroke Risk Factors and Epidemiology
S41 - Imaging in Movement Disorders
S42 - Neuromuscular Disorders
Presentation of the John Dystel Prize for Multiple Sclerosis Research
3:45 PM-4:15 PM
Update on the Complementary Therapies for MS: An Evidence-based Review Vijayshree Yadav MD, FAAN
4:00 PM-4:45 PM
Living Through a Ransomware Cyberattack: One Practice's Story, Insights, and Perspectives Leeann Garms
Choosing a Career in Neurocritical Care Katharina Busl MD, MS
4:15 PM-5:00 PM
Is There a Neurologist in the Stands? Javier Cardenas MD, Glynnis Zieman MD
4:45 PM-5:30 PM
Clinical Neurophysiology Section Guided Poster Tour
5:00 PM-5:45 PM
Case Studies: When to Refer Patients for Cognitive Behavioral or Mindfulness-based Psychotherapies: Expanding the Neurologist's Toolkit David Perez MD, Gaston Baslet MD, Aneeta Saxena MD
Succeeding in Small and Solo Practice Michael Wynn DO, FAAN, Pooia Fattahi MD, Erica Austin DO
Perspectivas profesionales para neurólogos en los Estados Unidos y América Latina (Professional Perspectives for Neurologists in the United States and Latin America) Ildefonso Rodriguez-Leyva MD, FAAN, Pedro Gonzalez-Alegre MD
5:15 PM-6:15 PM
Standing on the Shoulders of Giants Vladimir Hachinski MD, DSc, FAAN

Thursday, May 9, 2019
7:00 AM-7:30 AM
So Your Paper Didn’t Get Accepted, Now What? Roy Strowd MD
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-9:00 AM
C205 - Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies David Herrmann MD, FAAN
C206 - Vascular Cognitive Impairment and Dementia: Current Status and Future Larry Goldstein MD, FAAN, FAHA
C207 - Emergency Neurology: Evaluation of Coma, Meningitis, and Viral Encephalitis in the Emergency Room Jose Suarez MD
C208 - Contemporary Concerns About Brain Death Determination Ariane Lewis MD
C209 - Movement Disorders for the General Neurologist I: New Concepts in the Diagnosis and Management of Parkinson's Disease Irene Litvan MD, FAAN
C210 - Low and High Pressure Headache: Clinical Presentation and Approach to Evaluation and Management Kathleen Digre MD, FAAN
C212 - Principles of Genomic Medicine: Clinical Exome Sequencing in Neurologic Disease Wayne Grody MD, PhD
C214 - Child Neurology: A Case-based Approach Elaine Wirrell MD, FAAN
8:00 AM-8:30 AM
Neuroscience of Bias Jose Posas MD
8:00 AM-8:45 AM
Creating, Evaluating, and Publishing Your Active Learning Modules Diana Barratt MD, MPH, FAAN
A Migraine in Room 3: Patient-centered Care for Residents Paul Schanfield MD
9:15 AM-11:30 AM
Controversies in Neurology Plenary Session Aleksandar Videnovic MD, MSc, FAAN, Amy Brooks-Kayal MD, FAAN
11:30 AM-6:30 PM
P5 - Poster Session 5
11:45 AM-12:30 PM
How Your Social Life Might Be Helping (or Harming) Your Brain Joel Salinas MD
12:00 PM-12:45 PM
A "How to and Why" of the Shared Medical Appointments: A Way to Meet the Needs of the Patient and Provider While Maximizing Clinical Time Nancy Isenberg MD, MPH, FAAN, Mary Rensel MD, FAAN
12:00 PM-1:00 PM
Who Wants to Be a Millionaire Jose Posas MD
1:00 PM-1:45 PM
Acupuncture Demonstration - 4 Gates Jennifer Bickel MD, FAAN
Are You My Mentor? Finding the Right Fit for Success in Research Holly Hinson MD, MCR, FAAN
Become an Advocacy Leader: When There's No Seat at the Table, Make Your Own Table! Nikesh Bajaj DO
1:00 PM-2:30 PM
S44 - History of Neurology
Preview Film on Robin Williams’ Journey with LBD with His Wife Susan Schneider Williams
1:00 PM-3:00 PM
C215 - Peripheral Neuropathy II: Update on Diabetic, Immune Axonal, and Hematologic-related Neuropathies Michelle Mauermann MD, FAAN
C216 - Higher Cortical Visual Disorders: Case-based Review Sashank Prasad MD
C218 - Critical Care EEG Monitoring Suzette LaRoche MD, FAAN
C219 - Therapy in Neurology III: Epilepsy and Headache David Dodick MD, FAAN
C220 - Movement Disorders for the General Neurologist II: Tremor, Drug-induced Movement Disorders, RLS, and Ataxia Joohi Jimenez Shahed MD
C226 - Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease I Jeffrey Gelfand MD, MAS, FAAN
C221 - Functional Neurologic Disorders I: Movement, Seizures, and Multiple Sclerosis Alberto Espay MD, FAAN
C222 - Good Neurology in Challenging Conditions: Lessons from Military Neurology Michele Gatheridge MD
C223 - United We Stand: Enhancing Your Practice with APPs Jessica Erfan PA-C
C224 - Burnout and Resilience: Strategies and Evidence for Enhancing Wellbeing Jennifer Molano MD, FAAN
C225 - Actualización científica II (Scientific Update II) Alejandro Tobon MD
S45 - Neuroinfectious Disease: Treatments, Diagnostics, and Outcomes
S47 - Stroke Outcomes and Recurrence
S48 - Epilepsy/Clinical Neurophysiology (EEG) III
S49 - MS Epidemiology and Risk Stratification
1:00 PM-5:30 PM
C227 - Genomic Neurology: Developing Practical Knowledge of Tools and Concepts Through Case Studies Jeffery Vance MD, PhD
1:30 PM-2:30 PM
Rocky's Legacy: Historical Controversies of Boxing-related Concussions Barry Jordan MD, Anthony Alessi MD, FAAN, Tad Seifert MD
2:00 PM-2:45 PM
Innovative Ways to Decrease Wait Times in Your Practice Jason Sico MD, FAAN
3:00 PM-3:45 PM
How to Navigate the Demands of the First Years of Your Academic Career Nicholas Johnson MD, FAAN
3:00 PM-4:00 PM
Consejos prácticos para un buen examen neurológico (Neuro Exam Tips and Tricks) Jose Biller MD, FAAN, FACP, FAHA
3:30 PM-5:15 PM
S50 - Practice, Policy, and Ethics
3:30 PM-5:30 PM
C229 - Peripheral Neuropathy III: Genetic Neuropathies: Molecular Diagnosis and Treatment Perspectives Mario Saporta MD, PhD, FAAN
C230 - Disparities in Care Charles Flippen MD, FAAN
C231 - Safe and Appropriate Opioid Prescribing in Neurology Adam Burkey MD
C232 - Women With Epilepsy (WWE): Beyond Seizure Control Anne Van Cott MD, FAAN
C233 - Therapy in Neurology IV: Movement Disorders and Stroke David Dodick MD, FAAN
C234 - Movement Disorders for the General Neurologist III: Chorea, Dystonia, Myoclonus, Stereotypies, and Tics Shyamal Mehta MD, PhD
C236 - Neuro-rheumatology: Neurological Manifestations of Systemic Inflammatory and Autoimmune Disease II Jeffrey Gelfand MD, MAS, FAAN
C235 - Functional Neurologic Disorders II: Life Experiences and Management of Functional Disorders Alberto Espay MD, FAAN
S51 - Child Neurology: Bench to Bedside: Progress in Treating Genetic Disorders
S52 - Acute Non-Interventional Stroke Care
S53 - Movement Disorders: Genetics and Clinical Features
S54 - Motor Neuron Disease
S55 - MS Basic Science
IS3 - Invited Science: Aging and Dementia Karen Marder MD, MPH, FAAN, Heather Snyder PhD
4:00 PM-4:30 PM
Resident and Fellow Conversation Christopher Perrone MD
4:00 PM-4:45 PM
Neurohospitalist Models of Care in an Academic Department: Opportunities and Challenges S. Josephson MD, FAAN
4:30 PM-5:30 PM
Standing on the Shoulders of Giants Stanley Fahn MD, FAAN
5:00 PM-5:30 PM
Division Chief Conversation Amy Brooks-Kayal MD, FAAN
5:00 PM-5:45 PM
Influence of a Comprehensive Lifestyle Intervention on Prevention of Dementia Dean Sherzai MD, MAS, PhD, Ayesha Sherzai MD
Global Neurology: A Work in Progress Jerome Chin MD, PhD, MPH, FAAN
5:30 PM-6:00 PM
Division Chief Conversation Brenda Banwell MD, FAAN
7:00 PM-10:00 PM
C237 - Case Studies: Diagnosis and Management of Unusual Cases in Neuromuscular Disease Robert Pascuzzi MD, FAAN
C239 - Case Studies: Test Your Knowledge: A Case-based Approach to Neuroimaging Joshua Klein MD, PhD, FANA, FAAN
C240 - Case Studies: Unusual Movement Disorders Kailash Bhatia MD, FAAN
C241 - Case Studies: Challenging Headache Cases Kathleen Digre MD, FAAN
C242 - Case Studies: Dementia Gregory Day MD, MSc

Friday, May 10, 2019
7:00 AM-7:30 AM
Grant Writing 101: Getting Started Logan Schneider MD
Trainee Experience: Navigating the AAN and Your Career
7:00 AM-9:00 AM
C243 - Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis Michael Weiss MD, FAAN
C244 - Acute and Chronic Clinical Epilepsy Update Explained in 6 Cases Matthew Hoerth MD
C245 - Controversies in Stroke Treatment and Prevention Pierre Fayad MD, FAAN, FAHA
C246 - Hot Topics and Controversies in Parkinson's Disease Melissa Nirenberg MD, PhD, FAAN
C247 - What Do I Do Now?: Emergency and Inpatient Management of Migraine and Other Headache Disorders Stephanie Nahas MD, FAAN
C248 - Multiple Sclerosis in the Trenches: Controversy and Consensus in Clinical Decision-Making Aaron Miller MD, FAAN
C249 - Clinical Pearls: Learning from Complex Cases Simple Lessons that Apply to Everyday Problems S. Josephson MD, FAAN
8:00 AM-8:30 AM
How to Put Together Effective Research Presentations Enrique Leira MD, MS, FAAN
8:00 AM-8:45 AM
How to Give Effective Feedback Adnan Subei DO, Diana Barratt MD, MPH, FAAN, Farah Fourcand MD
9:15 AM-11:30 AM
Neurology Year in Review Plenary Session Martinson Arnan MD
11:30 AM-1:00 PM
P6 - Poster Session 6
11:45 AM-12:45 PM
Friday Grand Finale: Neuroimaging
12:00 PM-1:00 PM
The Neurology of Creativity at the Keyboard Phillip Pearl MD, FAAN
1:00 PM-1:45 PM
Growing Research in Medical Marijuana Anup Patel MD, FAAN
K is for Career Development: Tips on Successful Applications for NIH Career Development Awards Logan Schneider MD
1:00 PM-3:00 PM
C250 - Update in Epilepsy Joseph Sirven MD, FAAN
C252 - Update in Aging and Dementia Gil Rabinovici MD
C253 - Update in Movement Disorders Alfonso Fasano MD, PhD
S56 - MS Trials and Treatment
S57 - Acute Treatment and Imaging of Ischemic Stroke
S58 - Therapeutics in Neuromuscular Disorders
S59 - Migraine: Impact, Treatment Patterns and Resource Utilization
1:30 PM-2:15 PM
Movement Disorder Case Studies: What I Have Learned from My Patients Deborah Hall MD, PhD, FAAN, Susan Fox MD
2:00 PM-2:45 PM
Consensus-based Care Recommendations for Adults with Myotonic Dystrophy Type 1 Nicholas Johnson MD, FAAN
Consensus-Based Care Recommendations for Adults with haha
2:45 PM-3:30 PM
Neuroanatomy of the Zombie Brain: A Year in Review Brian Hanrahan MD
3:00 PM-3:45 PM
Sleep: Why You Should Spend Your Career Helping People Do It Right Logan Schneider MD
The Quality Road Map: Linking Guidelines, Quality Measures, and Axon Registry to Improve Care for Your Patients Anup Patel MD, FAAN
3:30 PM-4:30 PM
C254 - Education Blitz: Child Neurology: Concussion Meeryo Choe MD
C255 - Education Blitz: Normal Pressure Hydrocephalus Neill Graff-Radford MD, FAAN
C256 - Education Blitz: Emerging Infectious Diseases of the Central Nervous System Avindra Nath MD, MBBS, FAAN
C257 - Education Blitz: Evolution of Autoimmune Neurology Steven Vernino MD, PhD, FAAN
C258 - Education Blitz: Multiple Sclerosis Stephen Krieger MD, FAAN
4:30 PM-5:30 PM
NeuroZone Mark Milstein MD, FAAN, Bert Vargas MD, FAAN, Jennifer Bickel MD, FAAN, Wayne Anderson MD, FAAN

Universal Navigation

P4 - Poster Session 4

Ready to register for the 2019 AAN Annual Meeting?

Related Courses

Footer